6,119 results on '"Pathological Anatomy"'
Search Results
2. Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in HER2+ Breast Cancer Patients (IMMUN-HER)
- Author
-
University Hospital of Parma: Department of Biomedical, Biotechnological and Translational Sciences, Pathological Anatomy and Histology Unit, University Hospital of Parma:Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, University Hospital of Parma:Statistica medica ed epidemiologia clinica-UO Ricerca e Innovazione, Clirest s.r.l., Mipharm SpA, Arithmos srl, and Temas srl
- Published
- 2020
3. Follicular Dendritic Cell Sarcoma About A Case With Literature Review
- Author
-
L.Bahi, S.Berrada, Fz.Hzmiri,H.Rais Pathological Anatomy Service. FMPM-UCAM-CHU Mohamed VI 40000 Marrakech Morocco
- Subjects
follicular dendritic cells sarcoma, CD23, CXCL13 - Abstract
Follicular dendritic cell sarcomas (FDCS) are classified as histiocytic and dendritic cell neoplasms in the WHO 2017 classification of hematopoietic and lymphoid tissue tumors [1]. It is an extremely rare malignant tumor with morphological and phenotypic characteristics of follicular dendritic cells (FDC) [2]. These are derived from the mesenchymal stromal cells of the lymphoid follicles. They are an indispensable link between innate and adaptive immune responses. In this study, we raise through two observations the positive and differential diagnostic difficulties of this entity and we recall its morphological, immunohistochemical and evolutionary characteristics. Only 400 cases of FDCS are described in the literature. Our observation raises the problems of differential diagnosis frequently posed by follicular dendritic cell sarcoma. The main differential diagnosis is with metastasis of undifferentiated carcinoma. The positivity of the dendritic follicular markers (CXCL13, CD21, CD35, FDCSP and SRGN) makes it possible to affirm the diagnosis. Surgery is the treatment of reference. Dendritic follicular cell sarcomas are a nosological entity that is still under debate. Given their diagnostic difficulties, the demand for histological proof reading within the frame work of a specialized network is of great interest.
- Published
- 2019
- Full Text
- View/download PDF
4. Rare Localization Of An Extrapleural Solitary Fibrous Tumor: A Case With Literature Review
- Author
-
L.Bahi, S.Berrada, Fz.Hzmiri,H.Rais Pathological Anatomy Service. FMPM-UCAM-CHU Mohamed VI 40000 Marrakech Morocco
- Subjects
Solitary fibrous tumor, skin, STAT6 - Abstract
The solitary fibrous tumor (TFS) is a rare mesenchymal tumor, described initially in the pleura, but can sit in any anatomical site. Subcutaneous localization in the lumbar region is rarely described. We report through this work the main super pleural localizations currently described, as well as the most characteristic elements of the diagnosis in terms of histological and immunohistochemical analysis likely to improve their recognition. This is a 36-year-old woman who was seen for subcutaneous parietal mass in the lumbar region. The histological aspect and the immunohistochemical profile made it possible to evoke the diagnosis of solitary fibrous tumor. The TFS has the same anatomo-clinical characteristics regardless of its seat. It occurs in adults between 26 and 82 years, with no predominance of sex. It is most often asymptomatic. The radiological aspect is not specific. This unusual superficial presentation in the lumbar region may pose a diagnostic challenge, given the importance of the morphological and immunophenotypic spectrum and the overlap of SFT with other neoplasms. A fusion of the two NAB2-STAT6 genes by intrachromosomal inversion on chromosome 12 (q13q13) is found in 70 to 90% of cases. Postoperative monitoring is necessary given the risk of local recurrence in the absence of predictive criteria for the evolution.
- Published
- 2019
- Full Text
- View/download PDF
5. Clinical course of extensively drug-resistant tuberculosis with HIV infection and tertiary syphilis: a case report
- Author
-
Raznatovska, O. M.; Zaporizhzhia State Medical University, Ukraine, Fedorets, A. V.; Municipal Institution “Zaporizhzhia Regional Tuberculosis Clinical Dispensary”, Ukraine, Furyk, O. O.; Zaporizhzhia State Medical University, Ukraine, Makurina, H. I.; Zaporizhzhia State Medical University, Ukraine, Hrekova, T. O.; Zaporizhzhia State Medical University, Ukraine, Romashchenko, V. V.; Municipal Institution “Zaporizhzhia Regional Pathological Anatomy Bureau”, Ukraine, Raznatovska, O. M.; Zaporizhzhia State Medical University, Ukraine, Fedorets, A. V.; Municipal Institution “Zaporizhzhia Regional Tuberculosis Clinical Dispensary”, Ukraine, Furyk, O. O.; Zaporizhzhia State Medical University, Ukraine, Makurina, H. I.; Zaporizhzhia State Medical University, Ukraine, Hrekova, T. O.; Zaporizhzhia State Medical University, Ukraine, and Romashchenko, V. V.; Municipal Institution “Zaporizhzhia Regional Pathological Anatomy Bureau”, Ukraine
- Abstract
Purpose. To update the literature data with the clinical features of extensively drug-resistant tuberculosis (XDR-TB), HIV and tertiary syphilis co-infection course based on an example from own clinical experience.Materials and methods. A case report of XDR-TB with HIV and tertiary syphilis co-infection course was described based on our own clinical experience.Results. The presented clinical case confirms the partial literature data as we did not find such a combined course of XDR-TB with HIV infection and tertiary syphilis in the literature available. So, XDR-TB developed in the patient due to late diagnosed and untreated HIV infection. Neurosyphilis praecox developed secondary to Lues latens ignorata. Early diagnosis of tertiary syphilis was problematic owing to considerable similarity of XDR-TB and HIV infection clinical manifestations. The CD4+ T-lymphocyte count was 16 cells (with a viral load of 3483783 RNA copies/ml) indicating a pronounced immune system inhibition in the patient, causing progressive multiple organ failure, HIV-associated diseases (nephropathy, encephalopathy, cardiomyopathy) and visceral tertiary syphilis (the kidney and brain). Despite multimodality therapy (antimycobacterial, antiretroviral, symptomatic and pathogenetic therapy, treatment of syphilis), the patient died after 4 months of inpatient treatment. The immediate causes of death were wasting syndrome, mycobacteriosis, HIV infection-associated diseases manifested as mycobacterial infection and multiple diseases.Conclusions. Taking into account the considerable similarity of clinical and histological manifestations of tuberculosis and syphilis, as well as frequent HIV-associated tuberculosis (especially CRTB), it is recommended not to neglect the continuous use of a serological panel in patients with HIV and tuberculosis co-infection with the view to timely syphilis detecting. General practitioners are encouraged to work with patients towards the timely HIV testing. Also, it should, Цель работы – дополнение сведений научной литературы клиническими особенностями сочетанного течения туберкулеза с широкой лекарственной устойчивостью (ШЛУ-ТБ) с ВИЧ-инфекцией и третичным сифилисом на примере собственного наблюдения из практики.Материалы и методы. Описан клинический случай собственного наблюдения сочетанного течения ШЛУ-ТБ с ВИЧ-инфекцией и третичным сифилисом.Результаты. Представленный клинический случай подтверждает частичные данные научной литературы, поскольку такого сочетанного течения ШЛУ-ТБ с ВИЧ-инфекцией и третичным сифилисом в доступных специализированных источниках не нашли. Так, у пациентки на фоне поздно диагностированной и нелеченной ВИЧ-инфекции развился ШЛУ-ТБ. Neurosyphilis praecox развился на фоне Lues latens ignoratae. Ранняя диагностика третичного сифилиса была сложной из-за значительного сходства клинических проявлений ШЛУ-ТБ и ВИЧ-инфекции. Количество CD4-лимфоцитов составило 16 клеток (при вирусной нагрузке 3483783 РНК-копий/мл), что указывало на выраженное угнетение иммунной системы у больной и, как следствие, стало основой для прогрессирования полиорганной недостаточности, ВИЧ-ассоциированных заболеваний (нефропатии, энцефалопатии, кардиомиопатии) и третичного висцерального сифилиса (почек и головного мозга). Несмотря на проведение массивной комплексной терапии (антимикобактериальная, антиретровирусная, симптоматическая и патогенетическая терапии, лечение сифилиса), пациентка умерла через 4 месяца стационарного лечения. Непосредственными причинами смерти стали синдром истощения, микобактериоз, заболевание, обусловленное ВИЧ-инфекцией с проявлениями микобактериальной инфекции и множественных заболеваний.Выводы. Учитывая значительное сходство клинических и гистологических проявлений туберкулеза и сифилиса, а также частое присоединение к ВИЧ-инфекции туберкулеза (особенно химиорезистентного), у больных ВИЧ-инфекцией и туберкулезом рекомендовано не пренебрегать постоянным применением комплекса серологических исследований для сво, Мета роботи – доповнення відомостей фахової літератури клінічними особливостями поєднаного перебігу туберкульозу з широкою лікарською стійкістю (ШЛС-ТБ) із ВІЛ-інфекцією та третинним сифілісом на прикладі власного спостереження з практики.Матеріали та методи. Описано клінічний випадок власного спостереження поєднаного перебігу ШЛС-ТБ із ВІЛ-інфекцією та третинним сифілісом.Результати. Наведений клінічний випадок підтверджує часткові дані наукової літератури, оскільки протягом дослідження не знайшли такого поєднаного перебігу ШЛС-ТБ із ВІЛ-інфекцією та третинним сифілісом у доступних фахових джерелах. Так, у пацієнтки на тлі пізно діагностованої та нелікованої ВІЛ-інфекції виник ШЛС-ТБ. Neurosyphilis praecox розвинувся на тлі Lues latens ignoratae. Рання діагностика третинного сифілісу була складною через схожість клінічних проявів ШЛС-ТБ і ВІЛ-інфекції. Кількість CD4-лімфоцитів становила 16 клітин (при вірусному навантаженні 3483783 РНК-копій/мл), що вказувало на виражене пригнічення імунної системи у хворої та, як наслідок, стало основою для прогресування поліорганної недостатності, ВІЛ-асоційованих захворювань (нефропатії, енцефалопатії, кардіоміопатії) та третинного вісцерального сифілісу (нирок і головного мозку). Незважаючи на проведення масивної комплексної терапії (антимікобактеріальна, антиретровірусна, симптоматична та патогенетична терапії, лікування сифілісу), пацієнтка померла через 4 місяці стаціонарного лікування. Безпосередніми причинами смерті стали синдром виснаження, мікобактеріоз, захворювання, зумовлене ВІЛ-інфекцією з проявами мікобактеріальної інфекції та множинних захворювань.Висновки. Враховуючи суттєву схожість клінічних і гістологічних проявів туберкульозу та сифілісу, а також часте приєднання туберкульозу (особливо хіміорезистентого) до ВІЛ-інфекції, у хворих на ВІЛ-інфекцію та туберкульоз рекомендовано не нехтувати постійним застосуванням комплексу серологічних досліджень для своєчасного виявлення в організмі збудника сифілісу. Рекоменда
- Published
- 2019
6. Castleman–Kojima disease (TAFRO syndrome) in a Caucasian patient: A rare case report and review of the literature
- Author
-
Allegra, Alessandro, Rotondo, Francesco, Russo, Sabina, Calabrò, Laura, Maisano, Valerio, Division of Hematology, Department of General Surgery, Pathological Anatomy, University of Messina, 98125 Messina, Italy, ⁎Corresponding author at: Department of General Surgery, Oncology, Pathological Anatomy, University ofMessina, 98125 Messina, 1, Aallegra@unimeit, E. mail address: a. a. l. l. e. g. r. a. @. u. n. i. m. e. i. t., Bacci, Francesco, Hematopathology Section, Department of Experimental, School, Bologna, and Musolino, Caterina
- Subjects
medicine.medical_specialty ,Fatal outcome ,business.industry ,Giant lymph node hyperplasia ,MEDLINE ,Cell Biology ,Hematology ,Disease ,Dermatology ,Surgery ,Rare case ,Molecular Medicine ,Medicine ,business ,Molecular Biology - Published
- 2015
- Full Text
- View/download PDF
7. Особенности миграции меченых мезенхимальных стволовых клеток костного мозга в организме крыс, у которых моделировали паркинсоноподобный синдром
- Author
-
Pyatikop, Vladimir; Department of Neurosurgery, Kharkiv National Medical University, Kharkiv, Msallam Jr, Mohammad Ahmad; Department of Neurosurgery, Kharkiv National Medical University, Kharkiv, Shchegelskaya, Elena; Department of Neurosurgery, Kharkiv National Medical University, Kharkiv, Kutovoy, Igor; Department of Neurosurgery, Kharkiv National Medical University, Kharkiv, Gubina-Vakulik, Galina; Department of Pathological Anatomy, Kharkiv National Medical University, Kharkiv, Pyatikop, Vladimir; Department of Neurosurgery, Kharkiv National Medical University, Kharkiv, Msallam Jr, Mohammad Ahmad; Department of Neurosurgery, Kharkiv National Medical University, Kharkiv, Shchegelskaya, Elena; Department of Neurosurgery, Kharkiv National Medical University, Kharkiv, Kutovoy, Igor; Department of Neurosurgery, Kharkiv National Medical University, Kharkiv, and Gubina-Vakulik, Galina; Department of Pathological Anatomy, Kharkiv National Medical University, Kharkiv
- Abstract
Цель. Изучение локализации мезенхимальных стволовых клеток костного мозга (МСК КМ), меченных зеленым (DiO C18) и красным (Rhod Chol) витальными флуорохромами, после их внутривенного (ВВ) и интрацеребрального (ИЦ) введения в организм крыс, у которых моделировали паркинсоноподобный синдром (ПС).Материалы и методы. Животные распределены на 3 группы по 6 особей в каждой: I — контрольная, ВВ и ИЦ введение меченых МСК КМ; II — модель ПС и ВВ введение зеленых МСК КМ; III — модель ПС и ИЦ введение красных МСК КМ. Трансплантацию клеток проводили на 7-е сутки моделирования ПС. Эффективность трансплантации МСК оценивали по степени уменьшения выраженности двигательных расстройств, локализацию меченных флуорохромами клеток в органах крыс выявляли на криосрезах головного мозга, легких, селезенки, сердца, почек и печени с помощью люминесцентного микроскопа через 4 и 9 сут после введения МСК.Результаты. Флуоресцентные прижизненные красители DiO C18 (зеленый) и Rhod Chol (красный) могут быть эффективно использованы для изучения свойств МСК в культуре и их миграции в организме подопытных животных. Установлена избирательная миграция трансплантированных меченых МСК КМ к зонам повреждения головного мозга при моделировании ПС у крыс.Выводы. Для доставки МСК в поврежденную зону головного мозга могут быть использованы их как ИЦ, так и менее инвазивное ВВ введение., Мета. Вивчення локалізації мезенхімальних стовбурових клітин кісткового мозку (МСК КМ), мічених зеленим (DiO C18) і червоним (Rhod Chol) вітальними флуорохромами, після їх внутрішньовенного (ВВ) і інтрацеребрального (ІЦ) введення в організм щурів, у яких моделювали паркінсоноподібний синдром (ПС).Матеріали і методи. Тварини розподілені на 3 групи по 6 особин у кожній: I — контрольна, ВВ і ІЦ введення мічених МСК КМ; II — модель ПС і ВВ введення зелених МСК КМ; III — модель ПС і ІЦ введення червоних МСК КМ. Клітини трансплантували на 7-му добу моделювання ПС. Ефективність трансплантації МСК оцінювали за ступенем зменшення вираженості рухових розладів, локалізацію мічених флуорохромами клітин в органах щурів виявляли на кріосрезах головного мозку, легенів, селезінки, серця, нирок і печінки за допомогою люмінесцентного мікроскопа через 4 і 9 діб після введення МСК.Результати. Флуоресцентні прижиттєві барвники DiO C18 (зелений) і Rhod Chol (червоний) можна ефективно використовувати для вивчення властивостей МСК в культурі та їх міграції в організмі дослідних тварин. Встановлено селективну міграцію трансплантованих мічених МСК КМ до зон пошкодження головного мозку при моделюванні ПС у щурів.Висновки. Для доставки МСК у пошкоджену зону головного мозку можуть бути використані їх як ІЦ, так і менш інвазивне ВВ введення., The purpose. To study localization of bone marrow mesenchymal stem cells (BM MSC), labeled by green (DiO C18) and red (Rhod Chol) vital fluorochromes, after intravenous (IV) and intracerebral (IC) transplantation into rats with modeled Parkinson-like syndrome (PS).Materials and methods. The animals were divided into 3 groups, each of 6: I — control, IV and IC administration of labeled BM MSC; II — PS model and IV administration of green BM MSC; III — PS and IC transplantation of red BM MSC. Cell transplantation was performed on the 7th day after PS modeling. MSCs transplantation effectiveness was assessed by decrease of motor disorders degree, localization of fluorochrome labeled cells in the organs of rats was detected on cryosections of brain, lung, spleen, heart, kidneys and liver on the 4th and 9th day after MSC injection using fluorescence microscope.Results. Fluorescent vital dyes DiO C18 (green) and Rhod Chol (red) can be effectively used to study MSCs properties in culture and their migration in the body of experimental animals. Selective migration of transplanted labeled BM MSCs to damaged areas of the brain damage at PS modeling in rats was shown.Conclusions. For MSCs delivery in the brain damaged area their IC and less invasive IV transplantation can be used.
- Published
- 2014
8. Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology
- Author
-
José Trigo, Mónica García-Cosío, Almudena García-Castaño, Montserrat Gomà, Ricard Mesia-Nin, Elena Ruiz-Bravo, Ainara Soria-Rivas, Paola Castillo, Irene Braña-García, Margarita Alberola-Ferranti, Institut Català de la Salut, [Trigo J] HC Marbella International Hospital, Spanish Society of Medical Oncology (SEOM), Marbella, Spain. [García-Cosío M] Ramón y Cajal University Hospital, Spanish Society of Pathological Anatomy (SEAP), Madrid, Spain. [García-Castaño A] Marqués de Valdecilla University Hospital, Spanish Society of Medical Oncology (SEOM), Santander, Spain. [Gomà M] Bellvitge University Hospital, Spanish Society of Pathological Anatomy (SEAP), Hospitalet de Llobregat, Spain. [Mesia-Nin R] Catalan Institute of Oncology (ICO), Badalona Applied Research Group in Oncology, Germans Trias i Pujol Research Institute, Spanish Society of Medical Oncology (SEOM), Badalona, Spain. [Ruiz-Bravo E] La Paz University Hospital, Spanish Society of Pathological Anatomy (SEAP), Madrid, Spain. [Braña-García I] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Spanish Society of Medical Oncology (SEOM), Barcelona, Spain. [Alberola-Ferranti M] Vall d’Hebron Hospital Universitari, Spanish Society of Pathological Anatomy (SEAP), Barcelona, Spain, and Departament de Salut
- Subjects
PD-L1 ,Human papillomavirus ,Cancer Research ,Epstein-Barr Virus Infections ,Herpesvirus 4, Human ,Consensus ,factores biológicos::biomarcadores::marcadores tumorales [COMPUESTOS QUÍMICOS Y DROGAS] ,Cap - Càncer ,Medical Oncology ,Pathology and Forensic Medicine ,Glàndules salivals - Càncer ,Neoplasms::Neoplasms by Site::Head and Neck Neoplasms [DISEASES] ,neoplasias::neoplasias por localización::neoplasias de cabeza y cuello::neoplasias de la boca::neoplasias de las glándulas salivales [ENFERMEDADES] ,Individualized therapy ,Biomarkers, Tumor ,neoplasias::neoplasias por localización::neoplasias de cabeza y cuello [ENFERMEDADES] ,Humans ,Biological Factors::Biomarkers::Biomarkers, Tumor [CHEMICALS AND DRUGS] ,Epstein Barr virus ,General Medicine ,Prognosis ,Salivary Gland Neoplasms ,Neoplasms::Neoplasms by Site::Head and Neck Neoplasms::Mouth Neoplasms::Salivary Gland Neoplasms [DISEASES] ,Oncology ,Head and Neck Neoplasms ,Marcadors bioquímics ,Response to treatment - Abstract
Epstein Barr virus; Prognosis; Response to treatment Virus de Epstein Barr; Pronóstico; Respuesta al tratamiento Virus d'Epstein Barr; Pronòstic; Resposta al tractament The treatment of head and neck and salivary gland tumours is complicated and evolves constantly. Prognostic and predictive indicators of response to treatment are enormously valuable for designing individualized therapies, which justifies their research and validation. Some biomarkers, such as p16, Epstein–Barr virus, PD-L1, androgen receptors and HER-2, are already used routinely in clinical practice. These biomarkers, along with other markers that are currently under development, and the massively parallel sequencing of genes, ensure future advances in the treatment of these neoplasms. In this consensus, a group of experts in the diagnosis and treatment of tumours of the head and neck and salivary glands were selected by the Spanish Society of Pathology (Sociedad Española de Anatomía Patológica—SEAP) and the Spanish Society of Medical Oncology (Sociedad Española de Oncología Médica—SEOM) to evaluate the currently available information and propose a series of recommendations to optimize the determination and daily clinical use of biomarkers. SEOM and SEAP acknowledge the financial support for this project in the form of unrestricted collaboration in the logistics from AstraZeneca.
- Published
- 2022
9. PGI 2 Inhibits Intestinal Epithelial Permeability and Apoptosis to Alleviate Colitis
- Author
-
Camille Pochard, Anne Jarry, Guillaume Meurette, Maxime M. Mahe, Nicolas Cenac, Juliette Podevin, Emmanuel Coron, Michel Neunlist, Arnaud Bourreille, Malvyne Rolli-Derkinderen, Anne Bessard, Jacques Gonzales, The Enteric Nervous System in gut and brain disorders [U1235] (TENS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Institut de Recherche en Santé Digestive (IRSD ), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Ecole Nationale Vétérinaire de Toulouse (ENVT), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Anti-Tumor Immunosurveillance and Immunotherapy (CRCINA-ÉQUIPE 3), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Centre hospitalier universitaire de Nantes (CHU Nantes), Toulouse INSERM Metatoul-Lipidomique Core Facility-MetaboHub, the GIS-IBiSA program, the CIC 1413, the CCDE, and the Department of Pathological Anatomy and Cytology of the Hôtel-Dieu-Nantes hospital, SanteDige Foundation, GIS-IBiSA program, CIC 1413, the CCDE, and Department of Pathological Anatomy and Cytology of Hôtel-Dieu-Nantes hospital, ANR-19-CE14-0023,TACI,Ciblage de l'AMPK pour le contrôle la barrière épithéliale intestinale(2019), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), SEGUIN, Nathalie, and Ciblage de l'AMPK pour le contrôle la barrière épithéliale intestinale - - TACI2019 - ANR-19-CE14-0023 - AAPG2019 - VALID
- Subjects
Male ,0301 basic medicine ,[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO] ,RC799-869 ,Occludin ,DAI, Disease Activity Index ,IEC, intestinal epithelial cell ,Pathogenesis ,Mice ,0302 clinical medicine ,MLC, myosin light chain ,Intestinal mucosa ,Omega-6 (n-6) ,Medicine ,Intestinal Mucosa ,ANOVA, analysis of variance ,Original Research ,[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,IBD, inflammatory bowel disease ,medicine.diagnostic_test ,Dextran Sulfate ,Gastroenterology ,HRP, horseradish peroxidase ,Diseases of the digestive system. Gastroenterology ,Middle Aged ,GI, gastrointestinal ,Colitis ,Ulcerative colitis ,15-HETE, 15-hydroxyeicosatetraenoic acid ,3. Good health ,Caspase-3 ,Fatty Acids, Unsaturated ,ZO-1, zonula occludens ,Female ,030211 gastroenterology & hepatology ,UHA, unhealthy area ,medicine.symptom ,IEB, intestinal epithelial barrier ,PGI2 ,Adult ,HA, healthy area ,PCNA, proliferating cell nuclear antigen ,IBD ,PBS, phosphate-buffered saline ,Inflammation ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,[SDV.BC]Life Sciences [q-bio]/Cellular Biology ,SEM, standard error of the mean ,Permeability ,TEER, transepithelial electrical resistance ,Young Adult ,03 medical and health sciences ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,DSS, dextran sulfate sodium ,PUFA, polyunsaturated fatty acid ,Biopsy ,CD, Crohn’s disease ,[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO] ,Animals ,Humans ,Metabolomics ,IFN, interferon ,PG, prostaglandin ,[SDV.BC] Life Sciences [q-bio]/Cellular Biology ,Aged ,Tight Junction Proteins ,Intestinal permeability ,Hepatology ,business.industry ,qPCR, real-time quantitative polymerase chain reaction ,Lipidomic ,Inflammatory Bowel Diseases ,medicine.disease ,IP, prostaglandin I2 receptor ,Epoprostenol ,digestive system diseases ,IL, interleukin ,Mice, Inbred C57BL ,UC, ulcerative colitis ,Disease Models, Animal ,Human Mucosa ,030104 developmental biology ,Case-Control Studies ,Cancer research ,Caco-2 Cells ,business ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
Background & Aims Inflammatory bowel diseases (IBDs) that encompass both ulcerative colitis and Crohn’s disease are a major public health problem with an etiology that has not been fully elucidated. There is a need to improve disease outcomes and preventive measures by developing new effective and lasting treatments. Although polyunsaturated fatty acid metabolites play an important role in the pathogenesis of several disorders, their contribution to IBD is yet to be understood. Methods Polyunsaturated fatty acids metabolite profiles were established from biopsy samples obtained from Crohn’s disease, ulcerative colitis, or control patients. The impact of a prostaglandin I2 (PGI2) analog on intestinal epithelial permeability was tested in vitro using Caco-2 cells and ex vivo using human or mouse explants. In addition, mice were treated with PGI2 to observe dextran sulfate sodium (DSS)-induced colitis. Tight junction protein expression, subcellular location, and apoptosis were measured in the different models by immunohistochemistry and Western blotting. Results A significant reduction of PGI2 in IBD patient biopsies was identified. PGI2 treatment reduced colonic inflammation, increased occludin expression, decreased caspase-3 cleavage and intestinal permeability, and prevented colitis development in DSS-induced mice. Using colonic explants from mouse and human control subjects, the staurosporine-induced increase in paracellular permeability was prevented by PGI2. PGI2 also induced the membrane location of occludin and reduced the permeability observed in colonic biopsies from IBD patients. Conclusions The present study identified a PGI2 defect in the intestinal mucosa of IBD patients and demonstrated its protective role during colitis., Graphical abstract
- Published
- 2021
- Full Text
- View/download PDF
10. MicroRNA-34a activation in tuberous sclerosis complex during early brain development may lead to impaired corticogenesis
- Author
-
Josef Zamecnik, Anatoly Korotkov, Martha Feucht, Mark J. Luinenburg, Wim Van Hecke, Jeong H Lee, Caroline Mijnsbergen, Lieven Lagae, Till S. Zimmer, Wim G.M. Spliet, Floor E. Jansen, Katarzyna Kotulska, Jackelien van Scheppingen, Paolo Curatolo, Jasper J. Anink, Nam Suk Sim, Angelika Mühlebner, Pavel Krsek, Johannes A. Hainfellner, Sergiusz Jozwiak, Peter C. van Rijen, Erwin A. van Vliet, Diede W. M. Broekaart, David J. Kwiatkowski, Peter B. Crino, Anna Jansen, Eleonora Aronica, Anika Bongaarts, James D. Mills, Netherlands Institute for Neuroscience (NIN), Faculteit Economie en Bedrijfskunde, Cellular and Computational Neuroscience (SILS, FNWI), Pathological Anatomy, Public Health Sciences, Mental Health and Wellbeing research group, Neurogenetics, Neuroprotection & Neuromodulation, Pediatrics, Pathology, APH - Aging & Later Life, APH - Mental Health, Amsterdam Neuroscience - Cellular & Molecular Mechanisms, and Graduate School
- Subjects
0301 basic medicine ,Cortical tubers ,Male ,mTORC1 ,migration ,Tuberous sclerosis ,0302 clinical medicine ,Tuberous Sclerosis ,Child ,TSC ,Cerebral Cortex ,Neurons ,biology ,food and beverages ,Brain ,Hedgehog signaling pathway ,Cell biology ,Corticogenesis ,medicine.anatomical_structure ,Neurology ,Child, Preschool ,embryonic structures ,Female ,Original Article ,Astrocyte ,Signal Transduction ,Adult ,Histology ,Adolescent ,Pathology and Forensic Medicine ,03 medical and health sciences ,Young Adult ,Physiology (medical) ,medicine ,Animals ,Humans ,Mechanistic target of rapamycin ,miRNA ,fungi ,Infant ,Original Articles ,medicine.disease ,neurodevelopmental disorder ,Mice, Inbred C57BL ,MicroRNAs ,030104 developmental biology ,MicroRNA 34a ,Astrocytes ,biology.protein ,Neurology (clinical) ,mechanistic target of rapamycin ,030217 neurology & neurosurgery - Abstract
Aims Tuberous sclerosis complex (TSC) is a genetic disorder associated with dysregulation of the mechanistic target of rapamycin complex 1 (mTORC1) signalling pathway. Neurodevelopmental disorders, frequently present in TSC, are linked to cortical tubers in the brain. We previously reported microRNA‐34a (miR‐34a) among the most upregulated miRs in tubers. Here, we characterised miR‐34a expression in tubers with the focus on the early brain development and assessed the regulation of mTORC1 pathway and corticogenesis by miR‐34a. Methods We analysed the expression of miR‐34a in resected cortical tubers (n = 37) compared with autopsy‐derived control tissue (n = 27). The effect of miR‐34a overexpression on corticogenesis was assessed in mice at E18. The regulation of the mTORC1 pathway and the expression of the bioinformatically predicted target genes were assessed in primary astrocyte cultures from three patients with TSC and in SH‐SY5Y cells following miR‐34a transfection. Results The peak of miR‐34a overexpression in tubers was observed during infancy, concomitant with the presence of pathological markers, particularly in giant cells and dysmorphic neurons. miR‐34a was also strongly expressed in foetal TSC cortex. Overexpression of miR‐34a in mouse embryos decreased the percentage of cells migrated to the cortical plate. The transfection of miR‐34a mimic in TSC astrocytes negatively regulated mTORC1 and decreased the expression of the target genes RAS related (RRAS) and NOTCH1. Conclusions MicroRNA‐34a is most highly overexpressed in tubers during foetal and early postnatal brain development. miR‐34a can negatively regulate mTORC1; however, it may also contribute to abnormal corticogenesis in TSC., MicroRNA‐34a (MiR‐34a) is overexpressed in cortical tubers from children with tuberous sclerosis complex with a peak during infancy. MiR‐34a negatively regulates constitutively activated mechanistic target of rapamycin complex 1 in human astrocytes. MiR‐34a overexpression impairs corticogenesis in the embryonic mouse brain, potentially through targeting genes involved in neuronal migration.
- Published
- 2021
11. Transforming properties of Felis catus papillomavirus type 2 E6 and E7 putative oncogenes in vitro and their transcriptional activity in feline squamous cell carcinoma in vivo
- Author
-
Borzacchiello, Giuseppe [Department of Veterinary Medicine and Animal Productions, General Pathology and Pathological Anatomy Unit, University of Naples Federico II, Via Delpino 1, 80137 Naples (Italy)]
- Published
- 2016
- Full Text
- View/download PDF
12. Health Economic Impact of Software-Assisted Brain MRI on Therapeutic Decision-Making and Outcomes of Relapsing-Remitting Multiple Sclerosis Patients-A Microsimulation Study
- Author
-
Diana M. Sima, Wim Van Hecke, Guy Nagels, Dirk Smeets, Giovanni Esposito, Annemie Ribbens, Clinical sciences, Pathological Anatomy, Artificial Intelligence supported Modelling in clinical Sciences, Neuroprotection & Neuromodulation, and Neurology
- Subjects
medicine.medical_specialty ,Neuroscience(all) ,Microsimulation ,Clinical Neurology ,Context (language use) ,Neurosciences. Biological psychiatry. Neuropsychiatry ,Article ,Lesion ,Physical medicine and rehabilitation ,Atrophy ,Quality of life ,Medicine ,relapsing-remitting multiple sclerosis (RRMS) ,magnetic resonance imaging (MRI) ,brain MRI analysis software ,non-evidence of disease activity (NEDA) ,Markov model ,Magnetic resonance imaging (MRI) ,Subclinical infection ,business.industry ,General Neuroscience ,Multiple sclerosis ,medicine.disease ,Cohort ,medicine.symptom ,business ,RC321-571 - Abstract
Aim: To develop a microsimulation model to assess the potential health economic impact of software-assisted MRI in detecting disease activity or progression in relapsing-remitting multiple sclerosis (RRMS) patients. Methods: We develop a simulated decision analytical model based on a hypothetical cohort of RRMS patients to compare a baseline decision-making strategy in which only clinical evolution (relapses and disability progression) factors are used for therapy decisions in MS follow-up, with decision-making strategies involving MRI. In this context, we include comparisons with a visual radiologic assessment of lesion evolution, software-assisted lesion detection, and software-assisted brain volume loss estimation. The model simulates clinical (EDSS transitions, number of relapses) and subclinical (new lesions and brain volume loss) disease progression and activity, modulated by the efficacy profiles of different disease-modifying therapies (DMTs). The simulated decision-making process includes the possibility to escalate from a low efficacy DMT to a high efficacy DMT or to switch between high efficacy DMTs when disease activity is detected. We also consider potential error factors that may occur during decision making, such as incomplete detection of new lesions, or inexact computation of brain volume loss. Finally, differences between strategies in terms of the time spent on treatment while having undetected disease progression/activity, the impact on the patient’s quality of life, and costs associated with health status from a US perspective, are reported. Results: The average time with undetected disease progression while on low efficacy treatment is shortened significantly when using MRI, from around 3 years based on clinical criteria alone, to 2 when adding visual examination of MRI, and down to only 1 year with assistive software. Hence, faster escalation to a high efficacy DMT can be performed when MRI software is added to the radiological reading, which has positive effects in terms of health outcomes. The incremental utility shows average gains of 0.23 to 0.37 QALYs over 10 and 15 years, respectively, when using software-assisted MRI compared to clinical parameters only. Due to long-term health benefits, the average annual costs associated with health status are lower by $1500–$2200 per patient when employing MRI and assistive software. Conclusions: The health economic burden of MS is high. Using assistive MRI software to detect and quantify lesions and/or brain atrophy has a significant impact on the detection of disease activity, treatment decisions, health outcomes, utilities, and costs in patients with MS.
- Published
- 2021
- Full Text
- View/download PDF
13. Systemic sclerosis and microscopic polyangiitis after systemic exposure to silicone
- Author
-
Claudia Carrera Muñoz, Annabel Abó Rivera, Jorge González Rodríguez, Jordi Roig Cárcel, Elena Estaran, Alfons Segarra Medrano, Institut Català de la Salut, [Carrera Muñoz C, González Rodríguez J, Cárcel J] Department of Nephrology, Hospital Universitari Arnau de Vilanova, Lleida, Spain. [Abó Rivera A, Estarán E] Department of Pathological Anatomy, Hospital Universitari Arnau de Vilanova, Lleida, Spain. [Segarra Medrano A] Department of Nephrology, Hospital Universitari Arnau de Vilanova, Lleida, Spain. Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
Pathology ,medicine.medical_specialty ,Thrombotic microangiopathy ,systemic sclerosis ,silicon breast implants ,Exceptional Cases ,Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores] ,medicine.disease_cause ,Systemic scleroderma ,Autoimmunity ,chemistry.chemical_compound ,compuestos inorgánicos::elementos::metaloides::silicio [COMPUESTOS QUÍMICOS Y DROGAS] ,Silicone ,Other subheadings::Other subheadings::/adverse effects [Other subheadings] ,medicine ,AcademicSubjects/MED00340 ,Transplantation ,ASIA ,Malalties autoimmunitàries ,Silici - Efectes secundaris ,Implants artificials ,business.industry ,Immune System Diseases::Autoimmune Diseases [DISEASES] ,enfermedades del sistema inmune::enfermedades autoinmunes [ENFERMEDADES] ,Cytoplasmic antibody ,medicine.disease ,thrombotic microangiopathy ,crescentic glomerulonephritis ,chemistry ,Nephrology ,Inorganic Chemicals::Elements::Metalloids::Silicon [CHEMICALS AND DRUGS] ,Cohort ,ANCA anti-MPO vasculitis ,Microscopic polyangiitis ,Vasculitis ,business - Abstract
Glomerulonefritis creixent; Implants mamaris de silici; Esclerosi sistèmica Crescentic glomerulonephritis; Silicon breast implants; Systemic sclerosis Glomerulonefritis creciente; Implantes mamarios de silicio; Esclerosis sistémica The relationship between silicon breast implants (SBIs) and autoimmune/inflammatory syndrome induced by adjuvants (ASIA) has been extensively analysed, with discordant results. We present a 45-year-old woman with confirmed systemic exposure to SBI who developed systemic sclerosis (SSc) followed by anti-neutrophil cytoplasmic antibody anti-myeloperoxidase vasculitis with renopulmonary syndrome. The novelty of our case is, first, confirmation of systemic exposure to SBI and, second, chronologic development of not one, but two severe autoimmune diseases. Controversy may still remain regarding SBIs and ASIA because it is unclear that previous studies confirmed systemic exposure to silicon in their cohort of patients. Grant number: PI18/00356 - Instituto de Salud Carlos III - FEDER "Una manera de hacer Europa" - CERCA Programme/Generalitat de Catalunya - IRBLleida - Fundació Dr. Pifarré
- Published
- 2021
- Full Text
- View/download PDF
14. Cross-Resistance to Abiraterone and Enzalutamide in Castration Resistance Prostate Cancer Cellular Models Is Mediated by AR Transcriptional Reactivation
- Author
-
Ignacio Puche-Sanz, Pedro J. Real, Pablo Lupiañez, Sonia Perales, Iris Simon, Clara Alaminos, José A. Lorente, Alba Rodríguez-Martínez, Laura Casado-Medina, Juan J. Díaz-Mochón, María José Serrano, María del Carmen Garrido-Navas, [Simon,I, Perales,S, Casado-Medina,L, Lupiañez,P, Real,PJ] GENyO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government, Gene Regulation, Stem Cells & Development Lab, PTS Granada, Granada, Spain. [Simon,I, Real,PJ] Faculty of Science, Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain. [Rodríguez-Martínez,A, Garrido-Navas,MDC, Lorente,JA, Serrano,MJ] GENyO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government, Liquid Biopsy and Cancer Interception Group, PTS Granada, Granada, Spain. [Rodríguez-Martínez,A, Lorente,JA] Faculty of Medicine, Legal Medicine and Toxicology Department, University of Granada, Laboratory of Genetic Identification, Spain. [Garrido-Navas,MDC] Universidad Internacional de la Rioja, Logroño, Spain. [Puche-Sanz,I] Department of Urology, Bio-Health Research Institute (Instituto de Investigación Biosanitaria ibs.GRANADA), Hospital Universitario Virgen de las Nieves, University of Granada, Granada, Spain. [Diaz-Mochon, JJ] GENyO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government, Nanochembio Lab, PTS Granada, Granada, Spain. [Diaz-Mochon,JJ] Department of Pharmaceutical and Organic Chemistry, Faculty of Pharmacy, Campus de Cartuja, University of Granada, Granada, Spain. [Alaminos,C] Department of Urology, University Hospital of Jaen, Jaen, Spain. [Serrano,MJ] Comprehensive Oncology Division, Clinical University Hospital, Virgen de las Nieves-IBS, Granada, Spain. [Serrano,MJ] Department of Pathological Anatomy, Faculty of Medicine, University of Granada, Granada, Spain. [Real, PJ] Bio-Health Research Institute (Instituto de Investigación Biosanitaria ibs.GRANADA), Personalized Oncology Group, Granada, Spain, This study was supported by the Institute of Health Carlos III, Spain (PI17/00989) to M.J.S. and cofunded by the European Regional Development Fund 'A way to build Europe' and the Ramon y Cajal (RYC-2015-18382) to P.J.R., funded by the Ministry of Economy and Competitiveness. A.R.-M. was supported by the predoctoral-University Teacher Training Program from the Ministry of Education, Culture and Sport (FPU14/05461), I.S. was supported by the Young Researcher program from University of Granada (Joven Personal Investigador-Fondo Social Europeo, and Universidad de Granada (2018-19)) and a donation from Rolucan Association (Rota Lucha contra el Cancer).
- Subjects
0301 basic medicine ,Cancer Research ,Phenomena and Processes::Genetic Phenomena::Phenotype [Medical Subject Headings] ,castration resistant prostate cancer ,Cell ,Andrógenos ,urologic and male genital diseases ,Diseases::Male Urogenital Diseases::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasms::Prostatic Neoplasms, Castration-Resistant [Medical Subject Headings] ,Androgen deprivation therapy ,chemistry.chemical_compound ,Prostate cancer ,0302 clinical medicine ,Castration Resistance ,Anatomy::Cells::Cells, Cultured::Cell Line [Medical Subject Headings] ,androgen receptor ,abiraterone ,transcriptional regulation ,Abiraterone ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Cytological Techniques::Cytophotometry::Flow Cytometry [Medical Subject Headings] ,medicine.diagnostic_test ,Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Protein Isoforms [Medical Subject Headings] ,enzalutamide ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Androgen receptor ,medicine.anatomical_structure ,Elementos reguladores de la transcripción ,Oncology ,Chemicals and Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormone Antagonists::Androgen Antagonists [Medical Subject Headings] ,030220 oncology & carcinogenesis ,Castration resistant prostate cancer ,cross-resistance ,Check Tags::Male [Medical Subject Headings] ,lcsh:RC254-282 ,Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expression Regulation::RNA Processing, Post-Transcriptional::RNA Splicing::Alternative Splicing [Medical Subject Headings] ,Article ,Flow cytometry ,03 medical and health sciences ,Transcriptional regulation ,Psychiatry and Psychology::Behavior and Behavior Mechanisms::Motivation::Goals [Medical Subject Headings] ,Acetato de abiraterona ,medicine ,Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Androgens [Medical Subject Headings] ,Enzalutamide ,Cross-resistance ,Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Growth Processes::Cell Proliferation [Medical Subject Headings] ,Cell growth ,business.industry ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Urogenital Surgical Procedures::Castration [Medical Subject Headings] ,Neoplasias de la próstata resistentes a la castración ,medicine.disease ,030104 developmental biology ,chemistry ,Novel hormonal agents ,Cancer research ,Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Receptors, Cytoplasmic and Nuclear::Receptors, Steroid::Receptors, Androgen [Medical Subject Headings] ,business ,AR-V7 ,AR-V9 - Abstract
Androgen deprivation therapy (ADT) and novel hormonal agents (NHAs) (Abiraterone and Enzalutamide) are the goal standard for metastatic prostate cancer (PCa) treatment. Although ADT is initially effective, a subsequent castration resistance status (CRPC) is commonly developed. The expression of androgen receptor (AR) alternative splicing isoforms (AR-V7 and AR-V9) has been associated to CRPC. However, resistance mechanisms to novel NHAs are not yet well understood. Androgen-dependent PCa cell lines were used to generate resistant models to ADT only or in combination with Abiraterone and/or Enzalutamide (concomitant models). Functional and genetic analyses were performed for each resistance model by real-time cell monitoring assays, flow cytometry and RT-qPCR. In androgen-dependent PCa cells, the administration of Abiraterone and/or Enzalutamide as first-line treatment involved a critical inhibition of AR activity associated with a significant cell growth inhibition. Genetic analyses on ADT-resistant PCa cell lines showed that the CRPC phenotype was accompanied by overexpression of AR full-length and AR target genes, but not necessarily AR-V7 and/or AR-V9 isoforms. These ADT resistant cell lines showed higher proliferation rates, migration and invasion abilities. Importantly, ADT resistance induced cross-resistance to Abiraterone and/or Enzalutamide. Similarly, concomitant models possessed an elevated expression of AR full-length and proliferation rates and acquired cross-resistance to its alternative NHA as second-line treatment., Instituto de Salud Carlos III PI17/00989, European Regional Development Fund "A way to build Europe", Ramon y Cajal - Ministry of Economy and Competitiveness RYC-2015-18382, Ministry of Education, Culture and Sport FPU14/05461, University of Granada
- Published
- 2021
15. Increased 1,25(OH)2-Vitamin D Concentrations after Energy Restriction Are Associated with Changes in Skeletal Muscle Phenotype
- Author
-
Ignacio González López, Angela Vidal, Rafael Rios, Escolastico Aguilera-Tejero, Carmen Pineda, José-Luis L. Rivero, Ana I. Raya, [Vidal,A, Rios,R, Pineda,C, Lopez,I, Raya,AI, Aguilera-Tejero,E] Department of Animal Medicine and Surgery, University of Cordoba, Cordoba, Spain. [Vidal,A, Aguilera-Tejero,E] Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain. [Rivero,JLL] Department of Comparative Anatomy, Pathological Anatomy, and Toxicology, University of Cordoba, Cordoba, Spain., This research was funded by a Spanish Government Grant from the Instituto de Salud Carlos III, grant number PI17/00169 (Co-funded by FEDER, European Regional Development Fund, and 'A way to make Europe'/'Investing in your future')
- Subjects
0301 basic medicine ,Phenomena and Processes::Genetic Phenomena::Phenotype [Medical Subject Headings] ,Anatomy::Urogenital System::Urinary Tract::Kidney [Medical Subject Headings] ,muscle ,Muscle Fibers, Skeletal ,Riñón ,vitamin D ,Kidney ,0302 clinical medicine ,Chemicals and Drugs::Polycyclic Compounds::Steroids::Secosteroids::Vitamin D::Ergocalciferols [Medical Subject Headings] ,Anatomy::Tissues::Muscles::Muscle, Striated::Muscle, Skeletal::Muscle Fibers, Skeletal [Medical Subject Headings] ,Organisms::Eukaryota::Animals [Medical Subject Headings] ,rat ,Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Rats::Rats, Wistar [Medical Subject Headings] ,Phenomena and Processes::Metabolic Phenomena::Metabolism::Oxidative Stress [Medical Subject Headings] ,chemistry.chemical_classification ,Tibialis Cranialis ,Nutrition and Dietetics ,Chemistry ,energy restriction ,Muscle fibers ,medicine.anatomical_structure ,Phenotype ,Ergocalciferols ,Models, Animal ,Dieta ,Composition (visual arts) ,Female ,Restricción calórica ,Fenotipo ,lcsh:Nutrition. Foods and food supply ,Muscle Contraction ,medicine.medical_specialty ,Vitamina D ,Músculos ,030209 endocrinology & metabolism ,lcsh:TX341-641 ,Fibras musculares esqueléticas ,Oxidative phosphorylation ,Phenomena and Processes::Physiological Phenomena::Nutritional Physiological Phenomena::Diet [Medical Subject Headings] ,Article ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Models, Animal [Medical Subject Headings] ,Ratas ,03 medical and health sciences ,CYP24A1 ,Internal medicine ,medicine ,Vitamin D and neurology ,Animals ,Rats, Wistar ,Muscle, Skeletal ,Caloric Restriction ,Phenomena and Processes::Musculoskeletal and Neural Physiological Phenomena::Musculoskeletal Physiological Phenomena::Musculoskeletal Physiological Processes::Muscle Contraction [Medical Subject Headings] ,Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Biochemical Processes::Down-Regulation [Medical Subject Headings] ,Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Biochemical Processes::Up-Regulation [Medical Subject Headings] ,Skeletal muscle ,Phenomena and Processes::Metabolic Phenomena::Metabolism::Energy Metabolism [Medical Subject Headings] ,Diet ,Rats ,Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Rats [Medical Subject Headings] ,030104 developmental biology ,Enzyme ,Endocrinology ,Check Tags::Female [Medical Subject Headings] ,Energy Metabolism ,Food Science - Abstract
The influence of energy restriction (ER) on muscle is controversial, and the mechanisms are not well understood. To study the effect of ER on skeletal muscle phenotype and the influence of vitamin D, rats (n = 34) were fed a control diet or an ER diet. Muscle mass, muscle somatic index (MSI), fiber-type composition, fiber size, and metabolic activity were studied in tibialis cranialis (TC) and soleus (SOL) muscles. Plasma vitamin D metabolites and renal expression of enzymes involved in vitamin D metabolism were measured. In the ER group, muscle weight was unchanged in TC and decreased by 12% in SOL, but MSI increased in both muscles (p <, 0.0001) by 55% and 36%, respectively. Histomorphometric studies showed 14% increase in the percentage of type IIA fibers and 13% reduction in type IIX fibers in TC of ER rats. Decreased size of type I fibers and reduced oxidative activity was identified in SOL of ER rats. An increase in plasma 1,25(OH)2-vitamin D (169.7 ± 6.8 vs. 85.4 ± 11.5 pg/mL, p <, 0.0001) with kidney up-regulation of CYP27b1 and down-regulation of CYP24a1 was observed in ER rats. Plasma vitamin D correlated with MSI in both muscles (p <, 0.001), with the percentages of type IIA and type IIX fibers in TC and with the oxidative profile in SOL. In conclusion, ER preserves skeletal muscle mass, improves contractile phenotype in phasic muscles (TC), and reduces energy expenditure in antigravity muscles (SOL). These beneficial effects are closely related to the increases in vitamin D secondary to ER.
- Published
- 2021
16. The Polemic Diagnostic Role of TP53 Mutations in Liquid Biopsies from Breast, Colon and Lung Cancers
- Author
-
Garrido-Navas, M. Carmen, García-Díaz, Abel, Molina-Vallejo, Maria Pilar, González-Martínez, Coral, Alcaide Lucena, Miriam, Cañas-García, Inés, Bayarri, Clara, Delgado, Juan Ramón, González, Encarna, Lorente, Jose Antonio, Serrano, M. Jose, [Garrido-Navas,MC, García-Díaz,A, Molina-Vallejo,MP, González-Martínez,C, Alcaide Lucena,M, Cañas-García,I, Bayarri,C, Lorente,JA, Serrano,MJ] GENYO Centre for Genomics and Oncological Research, formed by Pfizer, the University of Granada and the Andalusian Regional Government, PTS Granada, Liquid Biopsy and Cancer Interception Group, Granada, Spain. [Garrido-Navas,MC] Universidad Internacional de la Rioja, Logroño, Spain. [García-Díaz,A] Departamento de Medicina, Facultad de Medicina, Universidad de Granada, Granada, Spain. [Alcaide Lucena,M, Cañas-García,I] Servicio de Cirugía General y del Aparato Digestivo, Hospital Clínico San Cecilio, Granada, Spain. [Bayarri,C] Department of Thoracic Surgery, Virgen de las Nieves University Hospital, Granada, Spain. [Delgado,JR, González,E, and Serrano,MJ] Bio-Health Research Institute (Instituto de Investigación Biosanitaria ibs. GRANADA), Complejo Hospitalario Universitario Granada (CHUG), University of Granada, Granada, Spain. [Lorente,JA] Laboratory of Genetic Identification, Department of Legal Medicine, University of Granada, Granada, Spain. [Serrano,MJ] Department of Pathological Anatomy, Faculty of Medicine, Campus de Ciencias de la Salud, University of Granada, Granada, Spain.
- Subjects
Anatomy::Cells::Neoplastic Cells, Circulating [Medical Subject Headings] ,Disciplines and Occupations::Natural Science Disciplines::Biological Science Disciplines::Biology [Medical Subject Headings] ,Tissue ,Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation [Medical Subject Headings] ,Liquid biopsy ,TP53 mutations ,CfDNA ,Diseases::Neoplasms [Medical Subject Headings] ,Technology and Food and Beverages::Technology, Industry, and Agriculture::Technology [Medical Subject Headings] ,CTC ,Neoplasias ,Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings] ,Persons::Persons::Patients [Medical Subject Headings] ,Tejidos ,Genes p53 ,Anatomy::Tissues [Medical Subject Headings] ,Concordance ,Biopsia líquida ,Pacientes ,Ácidos nucleicos libres de células ,Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genome::Genome Components::Genes::Genes, Neoplasm::Genes, Tumor Suppressor::Genes, p53 [Medical Subject Headings] ,Células neoplásicas circulantes - Abstract
Being minimally invasive and thus allowing repeated measures over time, liquid biopsies are taking over traditional solid biopsies in certain circumstances such as those for unreachable tumors, very early stages or treatment monitoring. However, regarding TP53 mutation status analysis, liquid biopsies have not yet substituted tissue samples, mainly due to the lack of concordance between the two types of biopsies. This needs to be examined in a study-dependent manner, taking into account the particular type of liquid biopsy analyzed, that is, circulating tumor cells (CTCs) or cell-free DNA (cfDNA), its involvement in the tumor biology and evolution and, finally, the technology used to analyze each biopsy type. Here, we review the main studies analyzing TP53 mutations in either CTCs or cfDNA in the three more prevalent solid tumors: breast, colon and lung cancers. We evaluate the correlation for mutation status between liquid biopsies and tumor tissue, suggesting possible sources of discrepancies, as well as evaluating the clinical utility of using liquid biopsies for the analysis of TP53 mutation status and the future actions that need to be undertaken to make liquid biopsy analysis a reality for the evaluation of TP53 mutations. Yes
- Published
- 2020
17. The Predictive Role of Raw Bioelectrical Impedance Variables in Disordered Eating Attitudes in Female Ballet Dance Students
- Author
-
Verónica Parent Mathias, José Ramón Alvero-Cruz, Miguel Angel Rosety, Ignacio Rosety, Jerónimo García Romero, Manuel Rosety-Rodriguez, Antonio Diaz, Francisco Javier Ordonez, Anatomía y Embriología Humana, Didáctica de la Educación Física, Plástica y Musical, Medicina, [Alvero-Cruz,JR, Parent Mathias,V, García Romero,JC] Department of Human Physiology, Histology, Pathological Anatomy and Physical Education and Sport, University of Málaga-Andalucía Technology Park, Málaga, Spain. [Alvero-Cruz,JR, García Romero,JC] The Biomedical Research Institute of Málaga (IBIMA), Málaga, Spain. [Alvero-Cruz,JR, García Romero,JC] School of Sports Medicine, Edificio López de Peñalver, Campus de Teatinos, Universidad de Málaga, Málaga, Spain. [Rosety,I, Rosety,MA, Ordoñez,FJ, Rosety-Rodriguez,M] School of Medicine, University of Cádiz, Cádiz, Spain. [Diaz,AJ] School of Nursing, University of Cádiz, Cádiz, Spain., and This study was supported by IBIMA (The Biomedical Research Institute of Málaga).
- Subjects
0301 basic medicine ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Physical Examination::Anthropometry [Medical Subject Headings] ,Trastornos de alimentación y de la ingestión de alimentos ,Body composition ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Confidence Intervals [Medical Subject Headings] ,Body Mass Index ,Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings] ,0302 clinical medicine ,phase angl ,disordered eating attitudes ,Statistics ,Electric Impedance ,Anthropology, Education, Sociology and Social Phenomena::Human Activities::Leisure Activities::Recreation::Dancing [Medical Subject Headings] ,Mathematics ,Nutrition and Dietetics ,Anthropometry ,Phase angle ,Area under the curve ,fat mass ,phase angle ,fat-free mass ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Research Design::Sensitivity and Specificity::Predictive Value of Tests [Medical Subject Headings] ,Psychiatry and Psychology::Mental Disorders::Eating Disorders [Medical Subject Headings] ,Body Composition ,Female ,Anthropology, Education, Sociology and Social Phenomena::Education::Students [Medical Subject Headings] ,Bioelectrical impedance analysis ,lcsh:Nutrition. Foods and food supply ,Psychiatry and Psychology::Behavior and Behavior Mechanisms::Attitude [Medical Subject Headings] ,Adolescent ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Anthropometry::Body Weights and Measures::Body Mass Index [Medical Subject Headings] ,Ballet ,030209 endocrinology & metabolism ,lcsh:TX341-641 ,ROC curves ,Article ,Persons::Persons::Age Groups::Adolescent [Medical Subject Headings] ,Feeding and Eating Disorders ,03 medical and health sciences ,Predictive Value of Tests ,Psychiatry and Psychology::Behavior and Behavior Mechanisms::Behavior::Behavior, Animal::Feeding Behavior [Medical Subject Headings] ,dance students ,Humans ,Disordered eating ,Dancing ,Students ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Sensitivity and Specificity::ROC Curve [Medical Subject Headings] ,Composición corporal ,Rank correlation ,Geographical Locations::Geographic Locations::Europe::Spain [Medical Subject Headings] ,030109 nutrition & dietetics ,Receiver operating characteristic ,reactance ,Curva ROC ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Area Under Curve [Medical Subject Headings] ,Andalucía ,Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Body Composition [Medical Subject Headings] ,Feeding Behavior ,skeletal muscle mass ,Confidence interval ,Feeding and eating disorders ,Attitude ,ROC Curve ,Antropometría ,Check Tags::Female [Medical Subject Headings] ,Phenomena and Processes::Physical Phenomena::Magnetic Phenomena::Electromagnetic Phenomena::Electricity::Electric Conductivity::Electric Impedance [Medical Subject Headings] ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Analysis of Variance [Medical Subject Headings] ,Food Science - Abstract
The present study used receiver operating characteristic (ROC) curve analysis to investigate the accuracy of body composition and raw bioelectrical impedance analysis (BIA) in correctly classifying disordered eating attitudes (DEA) in dance students. Participants were 81 female dancers assigned in two groups: beginner training (BT, age (mean ±, SD) = 10.09 ±, 1.2 years, n = 32) and advanced training (AT, age = 15.37 ±, 2.1 years, n = 49). Fat mass (FM) was estimated by Slaughter&rsquo, s equation and skeletal muscle with Poortman&rsquo, s equation. Impedance (Z), resistance (R), reactance (Xc) and phase angle (PhA) were obtained through multifrequency BIA at a frequency of 50 kHz. Fat-free mass (FFM) was assessed using Sun&rsquo, s equation. For evaluation of DEA, the Eating Attitudes Test-26 (EAT-26) questionnaire was performed. We defined an EAT-26 score &ge, 20 as positive for DEA. Comparisons between groups were performed by a one-way ANOVA test or Kruskall-Wallis test. Spearman&rsquo, s rank correlation coefficients were performed to assess associations between variables. ROC curve analysis was utilized to test the accuracy of body composition and BIA variables in predicting DEA. In the BT group, Xc and PhA demonstrated high accuracy in predicting DEA with an area under the curve (AUC) of 0.976 (95% confidence interval (CI): 0.85&ndash, 1.00) and 0.957 (95% CI: 0.82&ndash, 0.99), respectively, (both p <, 0.0001). FFM Sun had an AUC of 0.836 (95% CI: 0.66&ndash, 0.94) (p <, 0.0001) in the BT group and FFM Slaughter was 0.797 (95% CI: 0.66&ndash, 0.90) (p <, 0.001) in the AT group. Reactance and Phase angle were excellent and useful predictors of DEA in the BT group.
- Published
- 2020
18. A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms
- Author
-
Joris Winderickx, Joke Verelst, Nick Geukens, Mohamed Laghmouchi, Elien De Smidt, Erik Stoops, Debby Thomas, Eugeen Vanmechelen, Joelle Rosseels, Maria Bjerke, Luc Buée, Dorien Vliegen, Sofie Carmans, Sofie Molenberghs, Vanessa Franssens, Sabiha Eddarkaoui, Sebastiaan Engelborghs, Cindy Francois, Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), Lille Neurosciences & Cognition - U 1172 (LilNCog), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), ADx NeuroSciences NV [Ghent, Belgium], Institute Born-Bunge [Antwerp, Belgium], University of Antwerp (UA), Universitair Ziekenhuis Brussel = University Hospital of Brussels (UZ Brussel), Vrije Universiteit Brussel (VUB), Bio-Incubator [Heverlee, Belgium] (reMYND NV), BUEE, Luc, Lille Neurosciences & Cognition - U 1172 (LilNCog (ex-JPARC)), Universitair Ziekenhus Brussel (UZ Brussel), Clinical Biology, Clinical sciences, Neuroprotection & Neuromodulation, Neurology, and Pathological Anatomy
- Subjects
0301 basic medicine ,Gene isoform ,medicine.drug_class ,Transgene ,[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology ,Saccharomyces cerevisiae ,yeast ,Monoclonal antibody ,Biochemistry, Genetics and Molecular Biology (miscellaneous) ,Biochemistry ,Tau isoforms ,Epitope ,Insert (molecular biology) ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Molecular Biosciences ,[SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biochemistry [q-bio.BM] ,Molecular Biology ,[SDV.BBM.BC] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biochemistry [q-bio.BM] ,lcsh:QH301-705.5 ,Biology ,Original Research ,Medicine(all) ,biology ,Chemistry ,[SDV.NEU.NB] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology ,biology.organism_classification ,Molecular biology ,3. Good health ,030104 developmental biology ,lcsh:Biology (General) ,030220 oncology & carcinogenesis ,RNA splicing ,biology.protein ,monoclonal antibodies ,Antibody ,Tau ,conformational differences - Abstract
As human Tau undergoes pathologically relevant post-translational modifications when expressed in yeast, the use of humanized yeast models for the generation of novel Tau monoclonal antibodies has previously been proven to be successful. In this study, human Tau2N4R-ΔK280 purified from yeast was used for the immunization of mice and subsequent selection of high affinity Tau-specific monoclonal antibodies. The characterization of four novel antibodies in different Tau model systems yielded a phosphorylation-dependent antibody (15A10), an antibody directed to the first microtubule-binding repeat domain (16B12), a carboxy-terminal antibody (20G10) and an antibody targeting an epitope on the hinge of the first and second amino-terminal insert (18F12). The latter was found to be conformation-dependent, suggesting structural differences between the Tau splicing isoforms and allowing insight in the roles played by the amino-terminal inserts. As this monoclonal antibody also has the capacity to detect tangle-like structures in different transgenic Tau mice and neurofibrillary tangles in brain sections of patients diagnosed with Alzheimer's disease, we also tested the diagnostic potential of 18F12 in a pilot study and found this monoclonal antibody to have the ability to discriminate Alzheimer's disease patients from control individuals based on increased Tau levels in the cerebrospinal fluid. ispartof: Frontiers In Molecular Biosciences vol:7 ispartof: location:Switzerland status: Published online
- Published
- 2020
- Full Text
- View/download PDF
19. Glycosylation Pattern and in vitro Bioactivity of Reference Follitropin alfa and Biosimilars
- Author
-
Laura Riccetti, Samantha Sperduti, Clara Lazzaretti, Danièle Klett, Francesco De Pascali, Elia Paradiso, Silvia Limoncella, Francesco Potì, Simonetta Tagliavini, Tommaso Trenti, Eugenio Galano, Angelo Palmese, Abhijeet Satwekar, Jessica Daolio, Alessia Nicoli, Maria Teresa Villani, Lorenzo Aguzzoli, Eric Reiter, Manuela Simoni, Livio Casarini, Università degli Studi di Modena e Reggio Emilia (UNIMORE), Physiologie de la reproduction et des comportements [Nouzilly] (PRC), Institut Français du Cheval et de l'Equitation [Saumur]-Université de Tours-Centre National de la Recherche Scientifique (CNRS)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Università degli studi di Parma [Parme, Italie], LE STUDIUM Loire Valley Institute for Advanced Studies, This project has been supported by LE STUDIUM Loire Valley Institute for Advanced Studies, Orléans & Tours, France with funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 665790, Department of Obstetrics and Gynaecology, Fertility Center, University - Hospital of Modena and Reggio Emilia [Modena, Italy], Institut National de la Recherche Agronomique (INRA)-Institut Français du Cheval et de l'Equitation [Saumur]-Université de Tours-Centre National de la Recherche Scientifique (CNRS), Unit of Neurosciences, Department of Medicine and Surgery, University of Parma, Department of Laboratory Medicine and Pathological Anatomy, Azienda USL, Analytical Development Biotech Products, Chemistry Department, Merck Serono S.p.A., Center for Genomic Research, University of Modena and Reggio Emilia, Partenaires INRAE-Partenaires INRAE, Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria, ANR-10-LABX-0053,MAbImprove,Optimization of therapeutic monoclonal antibodies development - Better antibodies, better developed and better used(2010), European Project: 665790,H2020,H2020-MSCA-COFUND-2014,SMART LOIRE VALLEY(2015), University of Parma = Università degli studi di Parma [Parme, Italie], ANR-10-LABX-0053,MAbImprove,Optimization of therapeutic monoclonal antibodies development Better antibodies, better developed AND better used(2010), Institut Français du Cheval et de l'Equitation [Saumur]-Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Università degli Studi di Modena e Reggio Emilia = University of Modena and Reggio Emilia (UNIMORE), Institut Français du Cheval et de l'Equitation [Saumur] (IFCE)-Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), and Università degli studi di Parma = University of Parma (UNIPR)
- Subjects
0301 basic medicine ,endocrine system ,Glycan ,Glycosylation ,glycosylation ,medicine.drug_class ,[SDV]Life Sciences [q-bio] ,FSH ,biosimilar ,gonal-F ,bemfola ,ovaleap ,assisted reproduction (ART) ,Endocrinology, Diabetes and Metabolism ,This article was submitted to Reproduction ,030209 endocrinology & metabolism ,Pharmacology ,lcsh:Diseases of the endocrine glands. Clinical endocrinology ,follitropine ,law.invention ,réponse cellulaire ,03 medical and health sciences ,chemistry.chemical_compound ,Endocrinology ,0302 clinical medicine ,law ,Biologie de la reproduction ,medicine ,procréation médicalement assistée ,Original Research ,Reproductive Biology ,lcsh:RC648-665 ,biology ,Chemistry ,Lectin ,[SDV.BDLR]Life Sciences [q-bio]/Reproductive Biology ,[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism ,hormone folliculo-stimulante ,In vitro ,030104 developmental biology ,a section of the journal Frontiers in Endocrinology FSH ,biology.protein ,Recombinant DNA ,réponse induite ,Gonadotropin ,Intracellular ,Hormone - Abstract
Recombinant follicle-stimulating hormone (FSH) (follitropin alfa) and biosimilar preparations are available for clinical use. They have specific FSH activity and a unique glycosylation profile dependent on source cells. The aim of the study is to compare the originator (reference) follitropin alfa (Gonal-f (R))- with biosimilar preparations (Bemfola (R) and Ovaleap (R))-induced cellular responses in vitro. Gonadotropin N-glycosylation profiles were analyzed by ELISA lectin assay, revealing preparation specific-patterns of glycan species (Kruskal-Wallis test; p < 0.05, n = 6) and by glycotope mapping. Increasing concentrations of Gonal-f (R) or biosimilar (1 x 10(-3) -1 x 10(3) ng/ml) were used for treating human primary granulosa lutein cells (hGLC) and FSH receptor (FSHR)-transfected HEK293 cells in vitro. Intracellular cAMP production, Ca2+ increase and beta-arrestin 2 recruitment were evaluated by BRET, CREB, and ERK1/2 phosphorylation by Western blotting. 12-h gene expression, and 8- and 24-h progesterone and estradiol synthesis were measured by real-time PCR and immunoassay, respectively. We found preparation-specific glycosylation patterns by lectin assay (Kruskal-Wallis test; p < 0.001; n = 6), and similar cAMP production and beta-arrestin 2 recruitment in FSHR-transfected HEK293 cells (cAMP EC50 range = 12 +/- 0.9-24 +/- 1.7 ng/ml; beta-arrestin 2 EC50 range = 140 +/- 14.1-313 +/- 18.7 ng/ml; Kruskal-Wallis test; p >= 0.05; n = 4). Kinetics analysis revealed that intracellular Ca2+ increased upon cell treatment by 4 mu g/ml Gonal-f (R), while equal concentrations of biosimilars failed to induced a response (Kruskal-Wallis test; p < 0.05; n = 3). All preparations induced both 8 and 24 h-progesterone and estradiol synthesis in hGLC, while no different EC(50)s were demonstrated (Kruskal -Wallis test; p > 0.05; n = 5). Apart from preparation-specific intracellular Ca2+ increases achieved at supra-physiological hormone doses, all compounds induced similar intracellular responses and steroidogenesis, reflecting similar bioactivity, and overall structural homogeneity.
- Published
- 2019
- Full Text
- View/download PDF
20. Rnasequencing of trophectoderm cells biopsied from human blastocysts cultured in a new three-dimensional in vitro model reveal major pathways predicting implantation
- Author
-
Essahib, W., Aberkane, A., Verdyck, P., Guns, Y., Spits, C., Van Riet, I., Mackens, S., De Brucker, M., Verheyen, G., Tournaye, H., Van De Velde, H., Faculty of Medicine and Pharmacy, Basic (bio-) Medical Sciences, Reproductive immunology and implantation, Pathological Anatomy, Reproduction and Genetics, Vascular surgery, Centre for Reproductive Medicine - Gynaecology, Surgical clinical sciences, and Biology of the Testis
- Published
- 2019
21. MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma
- Author
-
Walmar Kerche de Oliveira, Claudia Nishida Hasimoto, Natália Bertoni, Sandra A. Drigo, Robson Francisco Carvalho, Maria Aparecida Marchesan Rodrigues, Giovanni Faria Silva, Silvia Regina Rogatto, Wan L. Lam, Juan Carlos Llanos, Luciana Schultz Amorim, Tomas Tokar, Márcio de Carvalho, Rainer Marco Lopez Lapa, Patricia P Reis, Leonardo Pelafsky, César Tadeu Spadella, Rogério Antonio de Oliveira, Tainara F. Felix, Universidade Estadual Paulista (Unesp), University Health Network, British Columbia Cancer Center, University of Southern Denmark, and Institute of Pathological Anatomy
- Subjects
0301 basic medicine ,Male ,endocrine system diseases ,Adaptive Immunity ,medicine.disease_cause ,Biochemistry ,0302 clinical medicine ,Cell Signaling ,Adenocarcinomas ,Medicine and Health Sciences ,Gene Regulatory Networks ,Immune Response ,Oligonucleotide Array Sequence Analysis ,Regulation of gene expression ,Multidisciplinary ,Middle Aged ,Acquired immune system ,humanities ,Up-Regulation ,Gene Expression Regulation, Neoplastic ,Nucleic acids ,Oncology ,030220 oncology & carcinogenesis ,Medicine ,Female ,Carcinoma, Pancreatic Ductal ,Research Article ,Signal Transduction ,Adult ,Ampulla of Vater ,Science ,Immunology ,Down-Regulation ,Ras Signaling ,Biology ,Carcinomas ,03 medical and health sciences ,Pancreatic Cancer ,Pancreatic cancer ,microRNA ,Gastrointestinal Tumors ,medicine ,Genetics ,Humans ,Non-coding RNA ,Aged ,Retrospective Studies ,Natural antisense transcripts ,Innate immune system ,Biology and life sciences ,Gene Expression Profiling ,Computational Biology ,Cancers and Neoplasms ,Cell Biology ,medicine.disease ,Immune checkpoint ,Immunity, Innate ,Acquired Immune System ,digestive system diseases ,Gene regulation ,Gene expression profiling ,Pancreatic Neoplasms ,MicroRNAs ,030104 developmental biology ,Immune System ,Cancer research ,RNA ,Gene expression ,Carcinogenesis - Abstract
Made available in DSpace on 2019-10-06T16:32:41Z (GMT). No. of bitstreams: 0 Previous issue date: 2019-05-01 Despite progress in treatment strategies, only ~24% of pancreatic ductal adenocarcinoma (PDAC) patients survive >1 year. Our goal was to elucidate deregulated pathways modulated by microRNAs (miRNAs) in PDAC and Vater ampulla (AMP) cancers. Global miRNA expression was identified in 19 PDAC, 6 AMP and 25 paired, histologically normal pancreatic tissues using the GeneChip 4.0 miRNA arrays. Computational approaches were used for miRNA target prediction/identification of miRNA-regulated pathways. Target gene expression was validated in 178 pancreatic cancer and 4 pancreatic normal tissues from The Cancer Genome Atlas (TCGA). 20 miRNAs were significantly deregulated (FC2 and p
- Published
- 2019
- Full Text
- View/download PDF
22. Late-onset thymidine kinase 2 deficiency: a review of 18 cases
- Author
-
Elena García Arumí, Bosco Méndez-Ferrer, Roberto Fernández-Torrón, Miguel A. Martín, Alberto Blázquez Encinar, Javier Sayas Catalán, Marti Ramon, Carmen Paradas, Germán Morís, Montse Olivé, Cecilia Jimenez-Mallebrera, Cristina Domínguez-González, Candela Caballero, Jorge García García, Jordi Díaz-Manera, Carmen Fuiza-Luces, María Carmen Badosa, Jesús Esteban, Aurelio Hernández-Laín, Joaquín Arenas, Michio Hirano, Ana Hernández-Voth, Frances Miralles, Eloy Rivas, [Dominguez-Gonzalez,C, Esteban,J] Neurology department, Neuromuscular disorders Unit, 12 de Octubre Hospital, Madrid, Spain. [Dominguez-Gonzalez,C, Fuiza-Luces,C, Esteban,J, Blazquez Encinar,A, Arenas,J, Martin,MA] Research Institute i+12, 12 de Octubre Hospital, Madrid, Spain. [Dominguez-Gonzalez,C, Díaz-Manera,J, Martí,C, García Arumi,E, Jimenez-Mallebrera,C, Martin,MA] Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain. [Hernández-Laín,A] Neuropathology, Pathology Department, Neuromuscular disorders Unit, 12 de Octubre Hospital, Madrid, Spain. [Rivas,E] Pathological Anatomic Department, Neuromuscular Disorders Unit, Instituto de Biomedicina de Sevilla, Hospital U. Virgen del Rocío, CSIC, Universidad de Sevilla, Sevilla, Spain. [Hernández-Voth,A, Sayas Catalán,J] Neumology department, Neuromuscular disorders Unit, 12 de Octubre Hospital, Madrid, Spain. [Fernández-Torrón,R] Neurology Department, Neuromuscular disorders Unit, Hospital de Donostia, San Sebastian, Spain. [Fuiza-Luces,C, Martin,MA] Mitochondrial and Neuromuscular Diseases Laboratory, Research Institute of Hospital '12 de Octubre' ('i+12'), Madrid, Spain. [García García,J] Neurology Department, Hospital de Albacete, Albacete, Spain. [Morís,G] Neurology Department, Neuromuscular disorders Unit, Hospital Central de Asturias, Oviedo, Spain. [Olivé,M] Pathological Anatomy Department, Neuromuscular disorders unit, IDIBELL-Hospital de Bellvitge, Barcelona, Spain. [Miralles,F] Neurology department, Neuromuscular disorders unit, Hospital Universitari Son Espases, Palma, Spain. [Díaz-Manera,J] Neurology department, Neuromuscular disorders unit, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain. [Caballero,C] Respiratory Department, Instituto de Biomedicina de Sevilla, Hospital U. Virgen del Rocío, CSIC, CIBERES, Universidad de Sevilla, Sevilla, Spain. [Méndez-Ferrer,B] Rehabilitation Department, Hospital Virgen del Rocio, Sevilla, Spain. [Martí,R, Badosa,MC, Jimenez-Mallebrera,C] Neuromuscular Unit, Neurology Department, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain. [García Arumi,E] Research group on Neuromuscular and Mitochondrial Diseases, Valld'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain. [Hirano,M] Department of Neurology, H. Houston Merritt Center, Columbia University Medical Center, New York, USA. [Paradas,C] Neurology Department, Neuromuscular Disorders Unit, Instituto de Biomedicina de Sevilla, Hospital U. Virgen del Rocío, CSIC, Universidad de Sevilla, Sevilla, Spain. [Paradas,C] Biomedical Network Research Centre on Neurodegenerative Diseases (CIBERNED), Madrid, Spain., This work was supported by research grants of Plan Nacional de I + D + I and Instituto de Salud Carlos III (ISCIII), Subdirección General de Evaluación y Fomento de la Investigación Sanitaria', project PI16–01843 (CP), PI16/00579 and CP09/00011 for CJM and the European Regional Development Fund (FEDER a way to achieve Europe). MAM has received funding from the Spanish ISCIII (grant PI 15/00431). A multicentric grant funded by the ISCIII (PMP15/00025 to MAM, RM, MO, CP)., Instituto de Biomedicina de Sevilla (IBIS), Institut Català de la Salut, [Domínguez-González C] Neurology department, Neuromuscular disorders Unit, 12 de Octubre Hospital, Madrid, Spain. Research Institute i+12, 12 de Octubre Hospital, Madrid, Spain. Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain. [Hernández-Laín A] Neuropathology, Pathology Department, Neuromuscular disorders Unit, 12 de Octubre Hospital, Madrid, Spain. [Rivas E] Pathological Anatomic Department, Neuromuscular Disorders Unit, Instituto de Biomedicina de Sevilla, Hospital U. Virgen del Rocío, CSIC, Universidad de Sevilla, Sevilla, Spain. [Hernández-Voth A, Sayas Catalán J] Neumology department, Neuromuscular disorders Unit, 12 de Octubre Hospital, Madrid, Spain. [Fernández-Torrón R] Neurology Department, Neuromuscular disorders Unit, Hospital de Donostia, San Sebastian, Spain. [García Arumi E] Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain. Grup de recerca en Patologia Neuromuscular i Mitocondrial, Vall d’Hebron Institut de Recerca, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain., Vall d'Hebron Barcelona Hospital Campus, Instituto de Salud Carlos III, European Commission, and Ministerio de Economía y Competitividad (España)
- Subjects
0301 basic medicine ,Male ,Pathology ,Diseases::Musculoskeletal Diseases::Muscular Diseases [Medical Subject Headings] ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies::Retrospective Studies [Medical Subject Headings] ,humanos ,ADN ,Multiple deletions ,lcsh:Medicine ,adolescente ,afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::trastornos de aparición tardía [ENFERMEDADES] ,miopatías mitocondriales ,ADN mitocondrial ,030105 genetics & heredity ,DNA, mitochondrial ,Mitocondris ,Late Onset Disorders ,Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings] ,0302 clinical medicine ,Ptosis ,Mitochondrial myopathy ,Pharmacology (medical) ,Respiratory system ,Child ,Genetics (clinical) ,mediana edad ,enfermedades musculares ,Otros calificadores::Otros calificadores::/genética [Otros calificadores] ,Mitochondrial Myopathies ,Anatomy::Musculoskeletal System::Muscles::Muscle, Skeletal [Medical Subject Headings] ,General Medicine ,adulto ,Middle Aged ,Musculoskeletal Diseases::Muscular Diseases::Mitochondrial Myopathies [DISEASES] ,Mitochondria ,adulto joven ,Gene delention ,Músculs - Malalties - Aspectes genètics ,TK2 deficiency ,Female ,Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Thymidine Kinase [CHEMICALS AND DRUGS] ,medicine.symptom ,Persons::Persons::Age Groups::Adult::Young Adult [Medical Subject Headings] ,Adult ,Weakness ,medicine.medical_specialty ,Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation [Medical Subject Headings] ,Adolescent ,Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Late Onset Disorders [DISEASES] ,Check Tags::Male [Medical Subject Headings] ,Late onset ,macromolecular substances ,Timidina ,Mitochondrial depletion ,DNA, Mitochondrial ,Thymidine Kinase ,Persons::Persons::Age Groups::Adolescent [Medical Subject Headings] ,03 medical and health sciences ,Young Adult ,Muscular Diseases ,Eliminación de gen ,medicine ,Other subheadings::Other subheadings::/genetics [Other subheadings] ,Humans ,Persons::Persons::Age Groups::Child [Medical Subject Headings] ,Muscle, Skeletal ,Persons::Persons::Age Groups::Adult [Medical Subject Headings] ,mutación ,Malalties musculars ,Retrospective Studies ,Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids::DNA::DNA, Circular::DNA, Mitochondrial [Medical Subject Headings] ,business.industry ,Research ,lcsh:R ,estudios retrospectivos ,Mutació (Biologia) ,Muscle weakness ,Persons::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings] ,DNA ,medicine.disease ,Timidina quinasa ,timidina cinasa ,enfermedades del sistema nervioso::enfermedades neuromusculares::enfermedades musculares::miopatías mitocondriales [ENFERMEDADES] ,Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Thymidine Kinase [Medical Subject Headings] ,Check Tags::Female [Medical Subject Headings] ,Thymidine kinase ,Miopatías mitocondriales ,enzimas y coenzimas::enzimas::transferasas::fosfotransferasas::fosfotransferasas (grupo alcohol aceptor)::timidina cinasa [COMPUESTOS QUÍMICOS Y DROGAS] ,Mutation ,Diseases::Musculoskeletal Diseases::Muscular Diseases::Mitochondrial Myopathies [Medical Subject Headings] ,business ,030217 neurology & neurosurgery - Abstract
[Background] TK2 gene encodes for mitochondrial thymidine kinase, which phosphorylates the pyrimidine nucleosides thymidine and deoxycytidine. Recessive mutations in the TK2 gene are responsible for the ‘myopathic form’ of the mitochondrial depletion/multiple deletions syndrome, with a wide spectrum of severity., [Methods] We describe 18 patients with mitochondrial myopathy due to mutations in the TK2 gene with absence of clinical symptoms until the age of 12., [Results] The mean age of onset was 31 years. The first symptom was muscle limb weakness in 10/18, eyelid ptosis in 6/18, and respiratory insufficiency in 2/18. All patients developed variable muscle weakness during the evolution of the disease. Half of patients presented difficulty in swallowing. All patients showed evidence of respiratory muscle weakness, with need for non-invasive Mechanical Ventilation in 12/18. Four patients had deceased, all of them due to respiratory insufficiency. We identified common radiological features in muscle magnetic resonance, where the most severely affected muscles were the gluteus maximus, semitendinosus and sartorius. On muscle biopsies typical signs of mitochondrial dysfunction were associated with dystrophic changes. All mutations identified were previously reported, being the most frequent the in-frame deletion p.Lys202del. All cases showed multiple mtDNA deletions but mtDNA depletion was present only in two patients., [Conclusions] The late-onset is the less frequent form of presentation of the TK2 deficiency and its natural history is not well known. Patients with late onset TK2 deficiency have a consistent and recognizable clinical phenotype and a poor prognosis, due to the high risk of early and progressive respiratory insufficiency., This work was supported by research grants of Plan Nacional de I + D + I and Instituto de Salud Carlos III (ISCIII), Subdirección General de Evaluación y Fomento de la Investigación Sanitaria”, project PI16–01843 (CP), PI16/00579 and CP09/00011 for CJM and the European Regional Development Fund (FEDER a way to achieve Europe). MAM has received funding from the Spanish ISCIII (grant PI 15/00431). A multicentric grant funded by the ISCIII (PMP15/00025 to MAM, RM, MO, CP).
- Published
- 2019
23. β-Cell adaptation in pregnancy
- Author
-
Michael S. German, Luc Baeyens, S. Hindi, Robert L. Sorenson, Pathological Anatomy, Pathology/molecular and cellular medicine, and Beta Cell Neogenesis
- Subjects
0301 basic medicine ,Endocrinology, Diabetes and Metabolism ,beta-cell ,Review ,Reproductive health and childbirth ,Bioinformatics ,Mice ,Endocrinology ,Pregnancy ,insulin resistance ,Insulin-Secreting Cells ,Insulin Secretion ,Htr2b ,Insulin ,Medicine ,glucose ,Placental lactogen ,Pediatric ,education.field_of_study ,Diabetes ,Postpartum Period ,Htr1d ,Adaptation, Physiological ,β-cell ,serotonin ,Gestational diabetes ,medicine.anatomical_structure ,Gestational ,Female ,pregnancy ,gestational diabetes ,Serotonin ,insulin ,medicine.medical_specialty ,mice ,placenta ,Physiological ,1.1 Normal biological development and functioning ,Clinical Sciences ,Population ,Article ,placental lactogen ,RATS ,Endocrinology & Metabolism ,03 medical and health sciences ,Insulin resistance ,Underpinning research ,Internal medicine ,Placenta ,Journal Article ,Internal Medicine ,Animals ,Humans ,Adaptation ,education ,Metabolic and endocrine ,Cell Proliferation ,business.industry ,Contraception/Reproduction ,Pancreatic islets ,Perinatal Period - Conditions Originating in Perinatal Period ,medicine.disease ,Rats ,Htr3a ,Diabetes, Gestational ,cell proliferation ,Glucose ,030104 developmental biology ,Insulin Resistance ,business ,Postpartum period - Abstract
Pregnancy in placental mammals places unique demands on the insulin-producing β-cells in the pancreatic islets of Langerhans. The pancreas anticipates the increase in insulin resistance that occurs late in pregnancy by increasing β-cell numbers and function earlier in pregnancy. In rodents, this β-cell expansion depends on secreted placental lactogens that signal through to the prolactin receptor. Then at the end of pregnancy, the β-cell population contracts back to its pre-pregnancy size. In the current review we focus on how glucose metabolism changes during pregnancy, how β-cells anticipate these changes through their response to lactogens, and what molecular mechanisms guide the adaptive compensation. In addition, we summarize current knowledge of β-cell adaptation during human pregnancy and what happens when adaptation fails and gestational diabetes ensues. A better understanding of human β-cell adaptation to pregnancy would benefit efforts to predict, prevent and treat gestational diabetes.
- Published
- 2016
- Full Text
- View/download PDF
24. The effect of task modality and stimulus frequency in paced serial addition tests on functional brain activity
- Author
-
Paul M. Parizel, Guy Nagels, Wim Van Hecke, Jeroen Van Schependom, Jorne Laton, Marie B. D'hooghe, Jeroen Gielen, Wietse Wiels, Faculty of Engineering, Neuroprotection & Neuromodulation, Faculty of Medicine and Pharmacy, Neurology, Clinical sciences, and Pathological Anatomy
- Subjects
0301 basic medicine ,Visual perception ,genetic structures ,Vision ,Social Sciences ,lcsh:Medicine ,Neuropsychological Tests ,Audiology ,Diagnostic Radiology ,Cognition ,Mathematical and Statistical Techniques ,0302 clinical medicine ,Functional Magnetic Resonance Imaging ,Medicine and Health Sciences ,Psychology ,Attention ,lcsh:Science ,Default mode network ,Brain Mapping ,Multidisciplinary ,medicine.diagnostic_test ,Agricultural and Biological Sciences(all) ,Cognitive Neurology ,Radiology and Imaging ,Information processing ,Brain ,Magnetic Resonance Imaging ,Memory, Short-Term ,Neurology ,Physical Sciences ,Female ,Sensory Perception ,Engineering sciences. Technology ,Statistics (Mathematics) ,Research Article ,Adult ,Computer and Information Sciences ,medicine.medical_specialty ,Neural Networks ,Imaging Techniques ,Cognitive Neuroscience ,Neuroimaging ,Research and Analysis Methods ,03 medical and health sciences ,Stimulus modality ,Diagnostic Medicine ,Neuropsychology ,Echo Planar Imaging ,medicine ,Humans ,Statistical Methods ,Neuropsychological Testing ,Analysis of Variance ,Modality (human–computer interaction) ,Working memory ,Biochemistry, Genetics and Molecular Biology(all) ,lcsh:R ,Biology and Life Sciences ,030104 developmental biology ,Acoustic Stimulation ,Cognitive Science ,lcsh:Q ,Human medicine ,Nerve Net ,Functional magnetic resonance imaging ,Photic Stimulation ,Psychomotor Performance ,Mathematics ,030217 neurology & neurosurgery ,Neuroscience - Abstract
Introduction The paced serial addition test (PSAT) is regularly used to assess cognitive deficits in various neuropsychiatric conditions. Being a complex test, it reflects the status of multiple cognitive domains such as working memory, information processing speed and executive functioning. Two versions of the PSAT exist. One uses auditory stimuli through spoken numbers and is known as the PASAT, while the other one presents patients with visual stimuli and is called PVSAT. The PASAT is considered more frustrating by patients, and hence the visual version is usually preferred. Research has suggested that an interference might exist between patients' verbal answers and the auditory presentation of stimuli. We therefore removed the verbal response in this study, and aimed to investigate differences in functional brain activity through functional magnetic resonance imaging. Methods Fifteen healthy controls performed the two test versions inside an MRI scanner-switching between stimulus modality (auditory vs. visual) as well as inter-stimulus frequency (3s vs. 2s). We extracted 11 independent components from the data: attentional, visual, auditory, sensorimotor and default mode networks. We then performed statistical analyses of mean network activity within each component, as well as inter-network connectivity of each component pair during the different task types. Results Unsurprisingly, we noted an effect of modality on activity in the visual and auditory components. However, we also describe bilateral frontoparietal, anterior cingulate and insular attentional network activity. An effect of frequency was noted only in the sensorimotor network. Effects were found on edges linking visual and auditory regions. Task modality influenced an attentional-sensorimotor connection, while stimulus frequency had an influence on sensorimotor-default mode connections. Conclusions Scanner noise during functional MRI may interfere with brain activation-especially during tasks involving auditory pathways. The question whether to use PVSAT or PASAT for an fMRI study is, therefore, an important one. Specific effects of both modalities should be known to study designers. We conclude that both tests should not be considered interchangeable, as significant changes were brought to light during test performance in different modalities.
- Published
- 2018
25. A Whole-Genome RNA Interference Screen Reveals a Role for Spry2 in Insulin Transcription and the Unfolded Protein Response
- Author
-
Michael S. German, Justin J Choe, Michael T. McManus, Deeksha Gambhir Chopra, Steven Chen, Hunter Richards, Katherine Yang, Zachary Pappalardo, Kenny K. H. Ang, Michelle R. Arkin, Gregory M. Ku, Luc Baeyens, Thomas G. Hennings, Pathological Anatomy, Pathology/molecular and cellular medicine, and Beta Cell Neogenesis
- Subjects
0301 basic medicine ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Endoplasmic Reticulum ,Medical and Health Sciences ,Mice ,eIF-2 Kinase ,RNA interference ,Transcription (biology) ,Insulin-Secreting Cells ,Glucose homeostasis ,Insulin ,2.1 Biological and endogenous factors ,Aetiology ,Annexin A5 ,Genetics ,biology ,Blotting ,Diabetes ,Intracellular Signaling Peptides and Proteins ,Genetics/Genomes/Proteomics/Metabolomics ,Protein-Serine-Threonine Kinases ,Cell biology ,Gene Knockdown Techniques ,RNA Interference ,Western ,Type 2 ,Biotechnology ,endocrine system ,mice ,1.1 Normal biological development and functioning ,Blotting, Western ,Protein Serine-Threonine Kinases ,Real-Time Polymerase Chain Reaction ,Cell Line ,Sarcoplasmic Reticulum Calcium-Transporting ATPases ,03 medical and health sciences ,Endocrinology & Metabolism ,Downregulation and upregulation ,Underpinning research ,Internal Medicine ,medicine ,Journal Article ,Diabetes Mellitus ,Animals ,Humans ,Transcription factor ,Metabolic and endocrine ,Membrane Proteins ,Insulin receptor ,030104 developmental biology ,Diabetes Mellitus, Type 2 ,Gene Expression Regulation ,Hyperglycemia ,biology.protein ,Unfolded protein response ,Unfolded Protein Response ,Calcium ,Generic health relevance ,Genome-Wide Association Study - Abstract
Insulin production by the pancreatic β-cell is required for normal glucose homeostasis. While key transcription factors that bind to the insulin promoter are known, relatively little is known about the upstream regulators of insulin transcription. Using a whole-genome RNA interference screen, we uncovered 26 novel regulators of insulin transcription that regulate diverse processes including oxidative phosphorylation, vesicle traffic, and the unfolded protein response (UPR). We focused on Spry2—a gene implicated in human type 2 diabetes by genome-wide association studies but without a clear connection to glucose homeostasis. We showed that Spry2 is a novel UPR target and its upregulation is dependent on PERK. Knockdown of Spry2 resulted in reduced expression of Serca2, reduced endoplasmic reticulum calcium levels, and induction of the UPR. Spry2 deletion in the adult mouse β-cell caused hyperglycemia and hypoinsulinemia. Our study greatly expands the compendium of insulin promoter regulators and demonstrates a novel β-cell link between Spry2 and human diabetes.
- Published
- 2017
26. Re-addressing the 2013 consensus guidelines for the diagnosis of insulitis in human type 1 diabetes
- Author
-
Heikki Hyöty, Thomas W.H. Kay, Alexandra E. Butler, Noel G. Morgan, Ben N G Giepmans, Alvin C. Powers, Sarah J. Richardson, Mark A. Atkinson, Martha Campbell-Thompson, Matthias von Herrath, Alberto Pugliese, Peter In't Veld, Pathological Anatomy, Pathology/molecular and cellular medicine, Diabetes Pathology & Therapy, Experimental Pathology, Center for Liver, Digestive and Metabolic Diseases (CLDM), and Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE)
- Subjects
0301 basic medicine ,type 1 diabetes ,medicine.medical_treatment ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,Inflammation ,Type 2 diabetes ,Human type ,Bioinformatics ,insulitis ,03 medical and health sciences ,0302 clinical medicine ,Diabetes mellitus ,medicine ,Internal Medicine ,Pancreas ,Type 1 diabetes ,business.industry ,Insulin ,medicine.disease ,030104 developmental biology ,medicine.anatomical_structure ,inflammation ,ONSET ,type 2 diabetes ,medicine.symptom ,islets of Langerhans ,business ,Insulitis ,Human - Published
- 2017
- Full Text
- View/download PDF
27. New insights on the biomineralisation process developing in human lungs around inhaled asbestos fibres
- Author
-
Fabrizio Bardelli, Elena Belluso, Giulia Veronesi, Laurent Charlet, Silvana Capella, Donata Bellis, Alessia Cedola, Soft and Living Matter Laboratory (S.Li.M. Lab), CNR Istituto di Nanotecnologia (NANOTEC), National Research Council of Italy | Consiglio Nazionale delle Ricerche (CNR)-National Research Council of Italy | Consiglio Nazionale delle Ricerche (CNR), Laboratoire de Chimie et Biologie des Métaux (LCBM - UMR 5249), Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), European Synchrotron Radiation Facility (ESRF), Università degli studi di Torino = University of Turin (UNITO), Department of Pathological Anatomy, ASL-TO1, Martini Hospital, via Tofane 71, 10154, Torino, Italy., Institut des Sciences de la Terre (ISTerre), Institut Français des Sciences et Technologies des Transports, de l'Aménagement et des Réseaux (IFSTTAR)-Institut national des sciences de l'Univers (INSU - CNRS)-Institut de recherche pour le développement [IRD] : UR219-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), CNR Istituto di Geoscienze e Georisorse (IGG ), National Research Council of Italy | Consiglio Nazionale delle Ricerche (CNR), Consiglio Nazionale delle Ricerche [Roma] (CNR)-Consiglio Nazionale delle Ricerche [Roma] (CNR), Department of Earth Sciences, University of Torino, Università degli studi di Torino (UNITO), Centre for Studies on Asbestos and other Toxic Particulates 'G. Scansetti', University of Torino, via Pietro Giuria 9, 10125, Turin, Italy., and Consiglio Nazionale delle Ricerche (CNR)
- Subjects
Male ,0301 basic medicine ,asbestos bodies ,synchrotron radiation ,biomineralization ,Biopsy ,Asbestosis ,010501 environmental sciences ,medicine.disease_cause ,Biomineralisation ,asbestos, FERRUGINOUS BODIES ,MALIGNANT MESOTHELIOMA ,X-RAY-ABSORPTION ,IRON STORAGE ,FERRIHYDRITE ,[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract ,01 natural sciences ,Coating ,MESOTHELIOMA ,Lung ,Chemical composition ,Aged, 80 and over ,Mineral Fibers ,Multidisciplinary ,biology ,Chemistry ,Calcinosis ,FERRUGINOUS BODIES ,CANCER ,[SDV.TOX]Life Sciences [q-bio]/Toxicology ,Female ,Iron ,Mineralogy ,engineering.material ,Article ,Asbestos ,03 medical and health sciences ,Ferrihydrite ,Metals, Heavy ,Occupational Exposure ,ASBESTOS ,medicine ,Humans ,0105 earth and related environmental sciences ,Radiochemistry ,BIOMINERALIZATION ,medicine.disease ,Trace Elements ,Ferritin ,030104 developmental biology ,Hemosiderin ,engineering ,biology.protein ,Biomineralization - Abstract
Once penetrated into the lungs of exposed people, asbestos induces an in vivo biomineralisation process that leads to the formation of a ferruginous coating embedding the fibres. The ensemble of the fibre and the coating is referred to as asbestos body and is believed to be responsible for the high toxicological outcome of asbestos. Lung tissue of two individuals subjected to prolonged occupational exposure to crocidolite asbestos was investigated using synchrotron radiation micro-probe tools. The distribution of K and of elements heavier than Fe (Zn, Cu, As, and Ba) in the asbestos bodies was observed for the first time. Elemental quantification, also reported for the first time, confirmed that the coating is highly enriched in Fe (~20% w/w), and x-ray absorption spectroscopy indicated that Fe is in the 3+ oxidation state and that it is present in the form of ferritin or hemosiderin. Comparison of the results obtained studying the asbestos bodies upon removing the biological tissue by chemical digestion and those embedded in histological sections, allowed unambiguously distinguishing the composition of the asbestos bodies, and understanding to what extent the digestion procedure altered their chemical composition. A speculative model is proposed to explain the observed distribution of Fe.
- Published
- 2017
- Full Text
- View/download PDF
28. White matter microstructure and volitional motor activity in schizophrenia
- Author
-
Timo De Bondt, Lise Docx, Bernard Sabbe, Manuel Morrens, Paul M. Parizel, Louise Emsell, Wim Van Hecke, Faculty of Psychology and Educational Sciences, Pathological Anatomy, Clinical sciences, Neuroprotection & Neuromodulation, and Clinical and Lifespan Psychology
- Subjects
Adult ,Male ,diffusion kurtosis ,Neuroscience (miscellaneous) ,Motor Activity ,Corpus callosum ,behavioral disciplines and activities ,White matter ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Fractional anisotropy ,medicine ,Cingulum (brain) ,Humans ,Radiology, Nuclear Medicine and imaging ,Diffusion Kurtosis Imaging ,Avolition ,Medicine(all) ,Brain Mapping ,Superior longitudinal fasciculus ,Brain ,Middle Aged ,White Matter ,030227 psychiatry ,schizophrenia ,Psychiatry and Mental health ,medicine.anatomical_structure ,Diffusion Magnetic Resonance Imaging ,Diffusion Tensor Imaging ,white matter microstructure ,imaging study ,Anisotropy ,Female ,Human medicine ,medicine.symptom ,Psychology ,Neuroscience ,volitional motor activity ,030217 neurology & neurosurgery ,Diffusion MRI - Abstract
Avolition is a core feature of schizophrenia and may arise from altered brain connectivity. Here we used diffusion kurtosis imaging (DKI) to investigate the association between white matter (WM) microstructure and volitional motor activity. Multi-shell diffusion MRI and 24-h actigraphy data were obtained from 20 right-handed patients with schizophrenia and 16 right-handed age and gender matched healthy controls. We examined correlations between fractional anisotropy (FA), mean diffusivity (MD), mean kurtosis (MK), and motor activity level, as well as group differences in these measures. In the patient group, increasing motor activity level was positively correlated with MK in the inferior, medial and superior longitudinal fasciculus, the corpus callosum, the posterior fronto-occipital fasciculus and the posterior cingulum. This association was not found in control subjects or in DTI measures. These results show that a lack of volitional motor activity in schizophrenia is associated with potentially altered WM microstructure in posterior brain regions associated with cognitive function and motivation. This could reflect both illness related dysconnectivity which through altered cognition, manifests as reduced volitional motor activity, and/or the effects of reduced physical activity on brain WM.
- Published
- 2017
29. Endometrial scratching
- Author
-
Claire Bourgain, Samuel Santos-Ribeiro, Christophe Blockeel, Pathological Anatomy, Reproductive immunology and implantation, Faculty of Medicine and Pharmacy, Surgical clinical sciences, and Reproduction and Genetics
- Published
- 2017
30. Atypical cerebral language dominance in a right-handed patient: An anatomoclinical study
- Author
-
Maarten Moens, Elke De Witte, Peter Mariën, Didier De Surgeloose, Guido Dua, Wim Van Hecke, Language and literature, Centre for Linguistics, Pathological Anatomy, Supporting clinical sciences, and Faculty of Economic and Social Sciences and Solvay Business School
- Subjects
Adult ,medicine.medical_specialty ,Electric Stimulation Therapy ,Neuropsychological Tests ,Audiology ,Functional Laterality ,Neurosurgical Procedures ,Lateralization of brain function ,Seizures ,Cerebellar hemisphere ,Journal Article ,Image Processing, Computer-Assisted ,Humans ,Medicine ,Arcuate fasciculus ,Broca's area ,Dominance, Cerebral ,Language ,Brain Mapping ,Case reports ,Language Tests ,Trail Making Test ,medicine.diagnostic_test ,Brain Neoplasms ,business.industry ,Cerebrum ,Research Support, Non-U.S. Gov't ,Wechsler Scales ,Neuropsychology ,Glioma ,General Medicine ,Magnetic Resonance Imaging ,Diffusion Tensor Imaging ,medicine.anatomical_structure ,nervous system ,Female ,Surgery ,Human medicine ,Neurology (clinical) ,business ,Functional magnetic resonance imaging ,Neuroscience ,Executive dysfunction - Abstract
Objective: Approximately 97% of the right-handers has left hemisphere language dominance. Within the language dominant hemisphere Broca's area is of crucial importance for a variety of linguistic functions. As a result, tumour resection in and around Broca's area is controversial. However, studies showed that by means of Direct Electrical Stimulation (DES) tumour resection in this region can be safely performed. We report unexpected anatomoclinical findings in a right-handed patient who underwent tumour resection in the left prefrontal lobe. Methods: Language functions in this right-handed patient were extensively examined in the pre-, intra, and postoperative phase by means of a standardised battery of neurolinguistic and neurocognitive tests. Results obtained in the pre- and postoperative phase are compared. In addition, intraoperative DES findings and postoperative functional Magnetic Resonance Imaging (fMRI) and Diffusion Tensor Imaging (DTI) results are reported. Results: Tumour resection near Broca's area was safely performed since no positive language sites were found during intraoperative DES. Since no linguistic deficits occurred in the pre-, intra-, or postoperative phase, atypical language dominance was suspected. Neuropsychological investigations, however, disclosed permanent executive dysfunction. Postoperative fMRI and DTI confirmed right cerebral language dominance as well as a crossed cerebro-cerebellar functional link with the left cerebellar hemisphere. Discussion: Atypical right hemisphere language dominance in this right-handed patient is reflected by: (1) the total absence of language problems in the pre-, intra- and postoperative phase, (2) absence of positive stimulation sites during DES, (3) a clearly more pronounced arcuate fasciculus in the right cerebral hemisphere (DTI), (4) a crossed functional connection between the right cerebrum and the left cerebellum (fMRI). Two hypothetical explanations for the pattern of crossed cerebral language dominance are put forward: (1) preoperative brain plasticity mechanisms inducing a shift of language functions to the right hemisphere or (2) right hemisphere language dominance as a maturational variant. This case with atypical cerebral language dominance shows that although DES is the 'gold standard' to identify eloquent language regions and their pathways, fMRI and DTI are important adjuncts to guide surgery, to identify language lateralisation and to study anatomoclinical correlations. (C) 2013 Elsevier B.V. All rights reserved.
- Published
- 2014
- Full Text
- View/download PDF
31. Omentum Is Better Site Than Kidney Capsule for Growth, Differentiation, and Vascularization of Immature Porcine β-Cell Implants in Immunodeficient Rats
- Author
-
Daniel Pipeleers, Sun Shouyue, Daniel Jacobs-Tulleneers-Thevissen, Karine Hellemans, Miriam Pipeleers-Marichal, Peter In't Veld, Krista Suenens, Kim Bartholomeus, Diabetes Pathology & Therapy, Basic (bio-) Medical Sciences, Surgery, Pathologic Biochemistry and Physiology, Vriendenkring VUB, Pathology/molecular and cellular medicine, Pathological Anatomy, and Surgical clinical sciences
- Subjects
Male ,medicine.medical_specialty ,Pathology ,Cell Survival ,Swine ,medicine.medical_treatment ,Islets of Langerhans Transplantation ,030209 endocrinology & metabolism ,Enteroendocrine cell ,Kidney ,Revascularization ,Cell therapy ,Rats, Nude ,03 medical and health sciences ,0302 clinical medicine ,Insulin-Secreting Cells ,Internal medicine ,medicine ,Animals ,Insulin ,Basic and Experimental Research ,Endocrine system ,Islet transplantation ,Rats, Wistar ,Endocrine pancreas ,Cell Proliferation ,030304 developmental biology ,0303 health sciences ,Transplantation ,geography ,geography.geographical_feature_category ,business.industry ,Islet ,Immunohistochemistry ,Rats ,3. Good health ,Endocrinology ,medicine.anatomical_structure ,Bromodeoxyuridine ,Glucagon-Secreting Cells ,Blood Vessels ,revascularization ,Implant ,business ,Omentum - Abstract
Islet intraportal transplantation is since long considered as therapy for type 1 diabetes (1). Clinical proof-of-concept has been provided since the early 1980s and initiated clinical trials worldwide (2–4). In most trials with human donor islets, the liver is still used as implant site, although there is growing awareness that this site is not optimal (5). It has been shown that several of its immunologic, anatomic, and physiologic features contribute to a significant early graft loss and β-cell dysfunction. Moreover, because this implant site is inaccessible, it can also not be considered when it comes to the use of alternative β-cell sources, such as stem cell–derived β cells or the use of xenografts (6–8). Several alternative sites have been tested in animal models to improve engraftment and long-term survival and to minimize surgical complications (6, 8). Few of these alternative sites hold the potential to be translated into clinical trials, and in general, evidence of posttransplantation functions better than those reached after intraportal infusion are lacking. The present study further assesses the omentum as implant site. This site was previously shown successful for rat islet isografts, which is in itself not particular because these preparations have functioned well in many sites (9, 10). When testing human islet cell grafts in diabetic immunodeficient rats, we found a better survival in the omentum than in the liver: omental implants exhibited little infiltration and were capable to correct hyperglycemia, whereas intraportal implants lost function after a heavy inflammatory infiltration (11). We now assess whether the omental site would also provide an adequate environment for growth of the β-cell mass as is known to occur in implants of immature pancreatic cell preparations (12–14). In a previous study, we have shown the growth potential of perinatal porcine β-cell grafts implanted under the kidney capsule of nude mice (15). The implants became structurally organized as homogenous endocrine clusters with predominantly insulin-positive cells and few other endocrine cells in the periphery; the increase in β-cell mass generated the potency to normalize diabetes (15, 16). Efficient revascularization is considered to be a prerequisite for this process (17). Within 2 days after implantation, we recognized the first endothelial cells and small blood vessels in the proximity of the implants; the revascularization process, however, proceeded beyond the 20-week study period (15, 18). It is conceivable that the rapidity and extent of this process determines initial engraftment as well as subsequent adaptive growth. Because the omentum is well vascularized and has been described as a rich source of angiogenic and neurogenic factors (19–21), we wanted to compare the growth of immature porcine β-cell grafts in omentum and kidney and relate it to the vessel density that has developed in both implants. Implants in the omentum reached vessel densities comparable with those in endogenous adult porcine islets within 10 weeks after implantation, which was not the case in the kidney subcapsular space. In parallel, implant volumes were increased reflecting a beneficial effect on β-cell proliferation and numbers as well as on cellular insulin content. Our data elaborate our prior findings with human islets implants and add further support on the potential use of the omentum as an alternative site for islet transplantation. Whether the omentum could offer an alternative to intraportal transplantation in humans remains to be evaluated.
- Published
- 2013
- Full Text
- View/download PDF
32. Abdominal Wall Desmoid Tumours
- Author
-
Jan Lamote, Guy Verfaillie, Marian Vanhoeij, Anne Hoorens, Surgery, Surgical clinical sciences, Pathological Anatomy, Translational Radiation Oncology and Physics, and Surgery Specializations
- Subjects
Adult ,medicine.medical_specialty ,business.industry ,Incisional hernia ,Composite mesh ,medicine.medical_treatment ,Abdominal Wall ,Fibromatosis, Abdominal ,General Medicine ,medicine.disease ,Magnetic Resonance Imaging ,Prosthesis ,Surgery ,Abdominal wall ,Radical excision ,medicine.anatomical_structure ,medicine ,Humans ,Female ,Desmoid tumours ,business - Abstract
We present two cases of desmoid tumour of the anterior abdominal wall in young women in whom the defect after radical excision could not be closed without using prosthesis. The first case warranted the use of a composite mesh, the second a polypropylene prosthesis. In both cases primary closure of the skin was possible. Both women are doing fine with no sign of relapse or incisional hernia.
- Published
- 2013
- Full Text
- View/download PDF
33. Radiation-induced breast angiosarcoma: a case report
- Author
-
Sara Pabón-Fernández, Manolo La Calle-Marcos, Diego Núñez-García, Rosa Albalat-Fernández, Sara Tato-Varela, [Tato-Varela,s, Albalat-Fernández,R, and La Calle-Marcos,M] Clinical Management Unit of Gynaecology and Obstetrics, Hospital Universitario Virgen Macarena, Seville, Spain. [Pabón-Fernández,S] Pathological Anatomy Service, Hospital Universitario Virgen Macarena, Seville, Spain. [Núñez-García,D] Family and Community Medicine, Hospital Universitario Virgen Macarena, Seville, Spain.
- Subjects
Cancer Research ,medicine.medical_specialty ,Neoplasias inducidas por radiación ,medicine.medical_treatment ,Hemangiosarcoma ,Radiation induced ,Case Report ,Secondary angiosarcoma ,Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings] ,03 medical and health sciences ,Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Sarcoma::Hemangiosarcoma [Medical Subject Headings] ,0302 clinical medicine ,Breast cancer ,breast cancer ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Incidence [Medical Subject Headings] ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Reconstructive Surgical Procedures::Mammaplasty [Medical Subject Headings] ,medicine ,breast reconstruction ,Breast reconstruction ,Diseases::Neoplasms::Neoplasms, Radiation-Induced [Medical Subject Headings] ,Anodyne ,Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms [Medical Subject Headings] ,Radiation ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Mortality::Survival Rate [Medical Subject Headings] ,business.industry ,Incidence (epidemiology) ,Breast angiosarcoma ,Analgésicos ,medicine.disease ,Surgery ,Radiation therapy ,radiation ,Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Peripheral Nervous System Agents::Sensory System Agents::Analgesics [Medical Subject Headings] ,Oncology ,Mamoplastia ,030220 oncology & carcinogenesis ,Neoplasias de la mama ,secondary angiosarcoma ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis [Medical Subject Headings] ,030211 gastroenterology & hepatology ,Radiology ,business - Abstract
Radiation-induced breast angiosarcoma is a severe but rare late complication in the breast-preserving management of breast cancer through surgery and radiotherapy [1]. Often the initial diagnosis of this entity is complex given its relatively anodyne nature and usually being present in the form of typically multifocal reddish-purple papular skin lesions [2]. Because of the low incidence of this tumour, there is a limited number of studies regarding its optimal therapeutic management [3]. The preferred treatment is aggressive surgical removal and the prognosis is poor with an overall survival rate of 12-20% at five years [4]. Yes
- Published
- 2016
34. A rare presentation of histologically proven sarcoidosis of the knee: A case report and brief review of the literature
- Author
-
A Riffi, Annieta Goossens, R Rongé, Frederik Vandenbroucke, K De Pierre, Walter Vincken, Evan Deschuyteneer, C Boulet, Faculty of Medicine and Pharmacy, Medical Imaging and Physical Sciences, Pathological Anatomy, Clinical sciences, Rehabilitation Research, and Medical Imaging
- Subjects
Adult ,Male ,medicine.medical_specialty ,Knee Joint ,Sarcoidosis ,Appendicular skeleton ,Pulmonary disease ,Disease ,law.invention ,Extrapulmonary sarcoidosis ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,Sarcoidosis, Pulmonary ,law ,Positron Emission Tomography Computed Tomography ,Biopsy ,medicine ,Humans ,Femur ,Osseous sarcoidosis ,Medicine(all) ,030203 arthritis & rheumatology ,medicine.diagnostic_test ,Tibia ,business.industry ,imaging ,General Medicine ,medicine.disease ,Magnetic Resonance Imaging ,Treatment ,medicine.anatomical_structure ,Radiological weapon ,Radiology ,Presentation (obstetrics) ,Bone Diseases ,business ,030217 neurology & neurosurgery - Abstract
We here report a patient with histologically proven sarcoidosis of the knee, a rare localization of sarcoidosis, which usually presents itself as a pulmonary disease. Case reports of radiological images that suggest osseous sarcoidosis of the appendicular skeleton are not so rare, however few are histologically proven. Since in our patient MRI could not distinguish between sarcoidosis and another (possibly malignant) disease, histological proof was obtained through a CT-guided biopsy. Imaging and treatment guidelines for extrapulmonary sarcoidosis are inexistent, due to lack of randomized trials.
- Published
- 2016
35. Making β(-like)-cells from exocrine pancreas
- Author
-
Gunter Leuckx, N. De Leu, Willem Staels, Luc Baeyens, Yves Heremans, M. Van de Casteele, Harry Heimberg, L. Bussche, S. De Groef, Pathology/molecular and cellular medicine, Beta Cell Neogenesis, Faculty of Medicine and Pharmacy, Diabetes Pathology & Therapy, Diabetes Clinic, Clinical sciences, and Pathological Anatomy
- Subjects
0301 basic medicine ,transdifferentiation ,Endocrinology, Diabetes and Metabolism ,Cell Plasticity ,Cell- and Tissue-Based Therapy ,Regenerative medicine ,Cell therapy ,03 medical and health sciences ,Endocrinology ,Directed differentiation ,Insulin-Secreting Cells ,Internal Medicine ,Acinar cell ,Diabetes Mellitus ,Medicine ,Humans ,Cellular Reprogramming Techniques ,Progenitor cell ,diabetes ,business.industry ,Transdifferentiation ,reprogramming ,Embryonic stem cell ,Pancreas, Exocrine ,beta cell ,030104 developmental biology ,Cell Transdifferentiation ,exocrine pancreas ,business ,Neuroscience ,Transcription Factors - Abstract
Creating an abundant source of β(-like)-cells has been a major goal in diabetes research for many decades. The concept of cell plasticity has inspired many strategies towards regenerative medicine, but its successes have been limited until very recently. Today, most cell types in the pancreas are considered candidates for the generation of β(-like)-cells through transdifferentiation. While β(-like)-cells that are in vitro differentiated from human embryonic stem cells are already being grafted in patients, β(-like)-cells generated by transdifferentiation are not yet ready for clinical application. These cells would however offer several advantages over the current β(-like)-cells generated by directed differentiation, especially concerning safety issues. In addition, perfect control of the transdifferentiation efficiency would through targeted drug delivery support a non-invasive cell therapy for diabetes. Lastly, focusing on the exocrine pancreas as prime candidate makes sense in view of their abundance and high plasticity. Keeping these hopeful perspectives in mind, it is worth to continue focused research on the mechanisms that control transdifferentiation from pancreas exocrine to β-cells.
- Published
- 2016
- Full Text
- View/download PDF
36. Reliable measurements of brain atrophy in individual patients with multiple sclerosis
- Author
-
Eva Havrdova, Anne-Marie Van Binst, Vasilis Terzopoulos, Annemie Ribbens, Melissa Cambron, Saurabh Jain, Johan De Mey, Jacques De Keyser, Wim Van Hecke, Diana M. Sima, Zdenek Seidl, Tomas Uher, Jan Krasensky, Dana Horakova, Manuela Vaneckova, Eline Van Vlierberghe, Anke Maertens, Guy Nagels, Dirk Smeets, Neuroprotection & Neuromodulation, Supporting clinical sciences, Clinical sciences, Translational Imaging Research Alliance, Medical Imaging, Body Composition and Morphology, and Pathological Anatomy
- Subjects
magnetic resonance images ,medicine.medical_specialty ,Fluid-attenuated inversion recovery ,multiple sclerosis ,030218 nuclear medicine & medical imaging ,Lesion ,03 medical and health sciences ,Behavioral Neuroscience ,0302 clinical medicine ,Atrophy ,Methods ,Medicine ,Psychology ,In patient ,Biology ,MSmetrix ,medicine.diagnostic_test ,business.industry ,Multiple sclerosis ,Disease progression ,Magnetic resonance imaging ,medicine.disease ,Treatment efficacy ,Physical therapy ,Radiology ,Human medicine ,medicine.symptom ,business ,030217 neurology & neurosurgery ,brain atrophy - Abstract
Introduction As neurodegeneration is recognized as a major contributor to disability in multiple sclerosis (MS), brain atrophy quantification could have a high added value in clinical practice to assess treatment efficacy and disease progression, provided that it has a sufficiently low measurement error to draw meaningful conclusions for an individual patient. Method In this paper, we present an automated longitudinal method based on Jacobian integration for measuring whole-brain and gray matter atrophy based on anatomical magnetic resonance images (MRI), named MSmetrix. MSmetrix is specifically designed to measure atrophy in patients with MS, by including iterative lesion segmentation and lesion filling based on FLAIR and T1-weighted MRI scans. Results MSmetrix is compared with SIENA with respect to test–retest error and consistency, resulting in an average test–retest error on an MS data set of 0.13% (MSmetrix) and 0.17% (SIENA) and a consistency error of 0.07% (MSmetrix) and 0.05% (SIENA). On a healthy subject data set including physiological variability the test–retest is 0.19% (MSmetrix) and 0.31% (SIENA). Conclusion Therefore, we can conclude that MSmetrix could be of added value in clinical practice for the follow-up of treatment and disease progression in MS patients.
- Published
- 2016
37. Sources of beta cells inside the pancreas
- Author
-
Mark Van de Casteele, Willem Staels, Marie Lemper, Yves Heremans, Nico De Leu, Gunter Leuckx, Naomi Van Gassen, Harry Heimberg, Sofie De Groef, Leen Bussche, Mozhdeh Sojoodi, Luc Baeyens, Yixing Yuchi, Pathology/molecular and cellular medicine, Beta Cell Neogenesis, Faculty of Medicine and Pharmacy, Medical Biochemistry, Toxicology, Dermato-cosmetology and Pharmacognosy, International Relations and Mobility, Clinical sciences, Pathological Anatomy, Diabetes Pathology & Therapy, and Diabetes Clinic
- Subjects
0301 basic medicine ,Endocrinology, Diabetes and Metabolism ,proliferation ,030209 endocrinology & metabolism ,Trnscription Factors ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Growth Factors ,Internal Medicine ,Medicine ,Regeneration ,Progenitor cell ,Induced pluripotent stem cell ,diabetes ,business.industry ,Embryonic stem cell ,humanities ,Transplantation ,beta cells ,030104 developmental biology ,medicine.anatomical_structure ,Immunology ,exocrine pancreas ,Cancer research ,Beta cell ,business ,Pancreas ,Reprogramming - Abstract
The generation of beta(-like) cells to compensate for their absolute or relative shortage in type 1 and type 2 diabetes is an obvious therapeutic strategy. Patients first received grafts of donor islet cells over 25 years ago, but this procedure has not become routine in clinical practice because of a donor cell shortage and (auto)immune problems. Transplantation of differentiated embryonic and induced pluripotent stem cells may overcome some but not all the current limitations. Reprogramming exocrine cells towards functional beta(-like) cells would offer an alternative abundant and autologous source of beta(-like) cells. This review focuses on work by our research group towards achieving such a source of cells. It summarises a presentation given at the 'Can we make a better beta cell?' symposium at the 2015 annual meeting of the EASD. It is accompanied by two other reviews on topics from this symposium (by Amin Ardestani and Kathrin Maedler, DOI: 10.1007/s00125-016-3892-9 , and by Heiko Lickert and colleagues, DOI: 10.1007/s00125-016-3949-9 ) and a commentary by the Session Chair, Shanta Persaud (DOI: 10.1007/s00125-016-3870-2 ).
- Published
- 2016
- Full Text
- View/download PDF
38. Cerebral and cerebellar language organization in a right-handed subject with a left temporal porencephalic cyst: An fMRI study
- Author
-
Mattias De Coninck, Roe Crols, Kim van Dun, Peter Paul De Deyn, Peter Marien, Marc Brysbaert, Wim Van Hecke, Debby Van Dam, Pathological Anatomy, Language and literature, Faculty of Arts and Philosophy, Centre for Linguistics, and Molecular Neuroscience and Ageing Research (MOLAR)
- Subjects
RIGHT-HEMISPHERIC ORGANIZATION ,DISORDER ,Linguistics and Language ,Cerebellum ,medicine.medical_specialty ,Cognitive Neuroscience ,LATERALIZATION ,FEATURES ,Experimental and Cognitive Psychology ,Audiology ,050105 experimental psychology ,Lateralization of brain function ,03 medical and health sciences ,0302 clinical medicine ,Arts and Humanities (miscellaneous) ,Supramarginal gyrus ,Cerebellar hemisphere ,FUNCTIONAL TOPOGRAPHY ,HISTORY ,medicine ,Psychology ,Verbal fluency test ,0501 psychology and cognitive sciences ,Language ,05 social sciences ,Neuropsychology ,Linguistics ,Bilateral ,medicine.disease ,Porencephaly ,Lobe ,BRAIN-LESIONS ,Cerebro-cerebellar network ,VERBAL FLUENCY ,medicine.anatomical_structure ,DOMINANCE ,Human medicine ,030217 neurology & neurosurgery ,Cognitive psychology ,MRI - Abstract
To test the hypothesis of crossed cerebro-cerebellar language dominance (Marien, Engelborghs, Fabbro, & De Deyn, 2001) in atypical populations, the pattern of cerebral and cerebellar language organization in a right-handed woman with a large porencephalic cyst in the left temporal lobe with no secondary clinical neurological symptoms was studied by means of an fMRI-language paradigm. Extensive neuropsychological examinations were performed to formally rule out cognitive dysfunctions. The fMRI task, consisting of a covert controlled oral word generation task, disclosed a pattern of bilateral activity in the frontal language areas, slightly more pronounced in the left hemisphere, and unilateral activation of the left inferior and superior temporal and supramarginal gyrus. This pattern of supratentorial activations was reflected at the infratentorial level by bilateral activations in the posterior lobe of the cerebellum with slightly more activity located in the right cerebellar hemisphere. This pattern of bilateral cerebral and cerebellar activation seems to confirm that the distribution of supratentorial language dominance is intrinsically reflected at the level of the cerebellum. Bilateral frontal language representation might be the consequence of neurofunctional compensation for the structural anomaly affecting eloquent brain regions resulting in an operational inefficiency of the neural network subserving language in the left hemisphere. (C) 2015 Elsevier Ltd. All rights reserved.
- Published
- 2016
39. Estimating the incidence of equine viral arteritis and the sensitivity of its surveillance in the French breeding stock
- Author
-
J. Tapprest, Aymeric Hans, P. Hendrikx, B. Ferry, J.P. Amat, Agnès Leblond, Barbara Dufour, Timothée Vergne, Unité de recherche d'Épidémiologie Animale (UEA), Institut National de la Recherche Agronomique (INRA), Dozulé Laboratory for Equine Diseases, Epidemiology and Pathological Anatomy Unit, Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES), Veterinary Epidemiology, Economics and Public Health Group, Royal Veterinary College, Institut Français du Cheval et de l'Equitation, Dozulé Laboratory for Equine Diseases, Virology Unit, Laboratory Affairs Department, Ecole nationale Veterinaire d'Alfort (ENVA) (EpiMAI USC Epi), École nationale vétérinaire d'Alfort (ENVA), Épidémiologie des Maladies Animales et Zoonotiques - UMR 346 (EPIA), Institut National de la Recherche Agronomique (INRA)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS), Unité de Recherche d'Épidémiologie Animale (UR EpiA), École nationale vétérinaire d'Alfort (ENVA)-Laboratoire de santé animale, sites de Maisons-Alfort et de Dozulé, and Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES)-Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES)
- Subjects
0301 basic medicine ,Veterinary medicine ,040301 veterinary sciences ,Epidemiology ,viruses ,[SDV]Life Sciences [q-bio] ,030106 microbiology ,Bayesian inference ,Surveillance sensitivity ,Selective breeding ,Antibodies, Viral ,Microbiology ,Disease Outbreaks ,0403 veterinary science ,Mark and recapture ,03 medical and health sciences ,Equartevirus ,Neutralization Tests ,Seroepidemiologic Studies ,Credible interval ,Animals ,Horses ,Seroconversion ,Surveillance ,General Veterinary ,biology ,Arterivirus Infections ,Incidence (epidemiology) ,Antibody titer ,Outbreak ,04 agricultural and veterinary sciences ,General Medicine ,Capture-recapture ,biology.organism_classification ,Virology ,Equine viral arteritis ,Female ,Horse Diseases ,Breeding stock ,France - Abstract
Equine viral arteritis (EVA) may have serious economic impact on the equine industry. For this reason, it is monitored in many countries, especially in breeding stock, to avoid its spread during breeding activities. In France, surveillance is mainly based on serological tests, since mares are not vaccinated, but difficulties in interpreting certain series of results may impair the estimation of the number of outbreaks. In this study, we propose specific rules for identifying seroconversion in order to estimate the number of outbreaks that were detected by the breeding stock surveillance component (BSSC) in France between 2006 and 2013. A consensus among multidisciplinary experts was reached to consider seroconversion as a change in antibody titer from negative to at least 32, or as an eight-fold or greater increase in antibody level. Using these rules, 239 cases and 177 outbreaks were identified. Subsequently, we calculated the BSSC's sensitivity as the ratio of the number of detected outbreaks to the total number of outbreaks that occurred in breeding stock (including unreported outbreaks) estimated using a capture-recapture model. The total number of outbreaks was estimated at 215 (95% credible interval 195-249) and the surveillance sensitivity at 82% (CrI95% 71-91). Our results confirm EVA circulation in French breeding stock, show that neutralizing antibodies can persist up to eight years in naturally infected mares and suggest that certain mares have been reinfected. This study shows that the sensitivity of the BSSC is relatively high and supports its relevance to prevent the disease spreading through mating.
- Published
- 2016
- Full Text
- View/download PDF
40. Selective culturing and genus-specific PCR detection for identification of Aeromonas in tissue samples to assist the medico-legal diagnosis of death by drowning
- Author
-
Jan Cordonnier, Geert Huys, Dirk Van Varenbergh, Vera Coopman, Pathological Anatomy, and Crime & Society
- Subjects
DNA, Bacterial ,Pathology ,medicine.medical_specialty ,food.ingredient ,Poison control ,Punctures ,Polymerase Chain Reaction ,Pathology and Forensic Medicine ,law.invention ,food ,Bone Marrow ,law ,Culture Techniques ,Ampicillin ,Humans ,Agar ,Medicine ,Forensic Pathology ,Lung ,Polymerase chain reaction ,DNA Primers ,Drowning ,biology ,business.industry ,biology.organism_classification ,DNA extraction ,Culture Media ,Blood ,medicine.anatomical_structure ,Aeromonas ,Case-Control Studies ,Aseptic processing ,Bone marrow ,business ,Law ,medicine.drug - Abstract
The detection of autochthonous aquatic bacteria in tissue samples from drowning cases is increasingly considered as an alternative approach to assist the medico-legal diagnosis of death by drowning. Bacteria belonging to the genus Aeromonas may be suitable candidates for this application as they are ubiquitous in natural aquatic environments but are generally not part of the human microbiota. The research aims of this study were (i) to develop a sensitive, specific and rapid screening and confirmation method for Aeromonas species in tissue samples and (ii) to evaluate aseptic sternal puncture as a post-mortem sample technique and bone marrow as an alternative matrix to provide evidence of death by drowning. The presence of Aeromonas in tissue samples was verified by cultivation using the selective media Ampicillin Dextrin Agar (ADA) and Ryan's Aeromonas Medium. The use of ADA medium was found most optimal for the sensitive, inexpensive and quick detection of aeromonads in human tissue samples. Positive culture plates were confirmed by harvesting all colonies for DNA extraction and subsequent PCR amplification using Aeromonas genus-specific primers. Aeromonads were detected in lung swab, blood and bone marrow of drowned bodies (n = 3), but were negative in these three matrices for all negative controls (n = 90) tested. Bone marrow proved to be a suitable alternative matrix and can be sampled post-mortem by an aseptic sternal puncture. In conclusion, this study confirms previous indications that aeromonads in cultures from blood of water bodies can be considered a potential marker for drowning. Given the fact that the number of immersed bodies (drowned and non-drowned) included in this study is statistically not significant, however, more tissue samples need to be investigated to confirm the validity of these methods to aid the diagnosis of death by wet drowning. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
- Published
- 2012
- Full Text
- View/download PDF
41. Laparoscopic resection of gastric gastrointestinal stromal tumors (GIST) is safe and effective, irrespective of tumor size
- Author
-
Patrick Haentjens, Georges Delvaux, Anne Hoorens, I. Van Loo, K. De Vogelaere, O. Peters, Surgery Specializations, Surgical clinical sciences, Pathological Anatomy, Medicine and Pharmacy academic/administration, Translational Radiation Oncology and Physics, and Internal Medicine Specializations
- Subjects
Male ,medicine.medical_specialty ,Stromal cell ,Gastrointestinal Stromal Tumors ,Gastroenterology ,Postoperative Complications ,Stomach Neoplasms ,Internal medicine ,medicine ,Humans ,Laparoscopic resection ,Prospective Studies ,Laparoscopy ,neoplasms ,Aged ,Retrospective Studies ,Tumor size ,medicine.diagnostic_test ,GiST ,business.industry ,Stomach ,digestive, oral, and skin physiology ,Length of Stay ,Middle Aged ,Hepatology ,digestive system diseases ,Tumor Burden ,Treatment Outcome ,primary gastric GIST ,medicine.anatomical_structure ,Feasibility Studies ,Female ,Surgery ,business ,Abdominal surgery - Abstract
BACKGROUND: Feasibility and long-term safety of laparoscopic removal of gastric gastrointestinal stromal tumors (GISTs) of the stomach is well established for lesions smaller than 2 cm. Our specific aim was to explore whether laparoscopic treatment is equally applicable for gastric GISTs larger than 2 cm. METHODS: Between 1997 and 2010, 31 consecutive patients presenting with a primary gastric GIST were scheduled for laparoscopic resection, irrespective of tumor size. Prerequisites for laparoscopic approach were the absence of metastases and the presence of a well-defined tumor on CT scanning without involvement of adjacent organs, the esophagogastric junction, or the pylorus of the stomach. Data were retrieved retrospectively from a prospectively collected database, including information on patient demographics, surgical procedure, complications, hospital stay, and recurrence. Diagnosis of GIST was based on microscopic analysis, including immunohistochemistry with a panel of antibodies: CD117, CD34, DOG1, S100, desmin, and smooth muscle actin. RESULTS: All 31 laparoscopic resections were carried out successfully. The most common symptoms were melena, anemia, and abdominal pain. In one case we performed a laparoscopic approach for a GIST with acute bleeding. Tumor size was smaller than 2 cm in 5 patients and larger than 2 cm in 26 patients. The median tumor size was 4.4 cm (range = 0.4-11.0 cm). Median blood loss was identical in both groups (20 ml), but duration of operation (60 vs. 103 min) and duration of hospital stay (6 vs. 8 days) were lower when tumor size was less than 2 cm. Only one patient (with tumor size CONCLUSION: The low morbidity rates and the long-term disease-free interval of 100% observed in our cohort indicate that laparoscopic resection is safe and effective in treating gastric GISTs, even for tumors larger than 2 cm. Comment in Combined laparoscopic and endoscopic excision of a gastric gist. [Surg Endosc. 2013]
- Published
- 2012
- Full Text
- View/download PDF
42. Invasive Recurrence of an Intestinal-Type Mucinous Epithelial Neoplasm of Low Malignant Potential: Case Report and Review of the Literature
- Author
-
Stefan Cosyns, P. De Sutter, M. Leyder, Claire Bourgain, Gyneacology-Urology, UZB Other, Pathological Anatomy, Reproductive immunology and implantation, Department of Embryology and Genetics, and Pathology
- Subjects
Intestinal type ,Pathology ,medicine.medical_specialty ,endocrine system ,Invasive recurrence ,endocrine system diseases ,business.industry ,Borderline ovarian tumor, intestinal-type ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Debulking ,medicine.disease ,lcsh:RC254-282 ,female genital diseases and pregnancy complications ,Ovarian tumor ,Epithelial neoplasm ,Oncology ,Borderline ovarian tumor, low malignant potential ,Mature teratoma ,Journal Article ,Medicine ,Pseudomyxoma peritonei ,Borderline ovarian tumor, mucinous ,Published: August 2011 ,Borderline ovarian tumors ,business - Abstract
Pseudomyxoma peritonei is only rarely seen in conjunction with primary ovarian tumors. It has been suggested that only ruptured mucinous tumors arising in ovarian mature cystic teratomas can result in this clinical picture. We describe a case of a late invasive recurrence of a mucinous intestinal-type borderline ovarian tumor arising from a mature teratoma after complete surgical debulking. Borderline ovarian tumors behave indolently in the overwhelming majority of cases, and the prognosis is therefore usually outstanding.
- Published
- 2011
43. Adult pancreatic acinar cells dedifferentiate to an embryonic progenitor phenotype with concomitant activation of a senescence programme that is present in chronic pancreatitis
- Author
-
Nele De Medts, Maximilian Reichert, Francisco X. Real, Luc Bouwens, Andreia V. Pinho, Anil K. Rustgi, Ilse Rooman, Cell Differentiation, Pathological Anatomy, and Laboratory for Medical and Molecular Oncology
- Subjects
Senescence ,medicine.medical_specialty ,Pancreatic disease ,transdifferentiation ,Biology ,Mice ,Pancreatitis, Chronic ,Internal medicine ,medicine ,Animals ,Progenitor cell ,Cells, Cultured ,Cellular Senescence ,Embryonic Stem Cells ,Ceruletide ,Reverse Transcriptase Polymerase Chain Reaction ,Gene Expression Profiling ,Gastroenterology ,reprogramming ,Cell Dedifferentiation ,medicine.disease ,Pancreas, Exocrine ,Up-Regulation ,Mice, Inbred C57BL ,Disease Models, Animal ,Phenotype ,Endocrinology ,medicine.anatomical_structure ,Cancer research ,PDX1 ,Pancreatic progenitor cell ,Stem cell ,Pancreas - Abstract
Objective Acinar cells display plasticity in vitro and in vivo and can activate a variety of differentiation programmes that may contribute to pancreatic diseases. The aims were to determine: (1) the differentiation potential of acinar cells under conditions which favour stem cell survival, and (2) its relationship to the phenotypes acquired by pancreatic epithelial cells in chronic pancreatitis. Design Murine acinar cells were cultured in suspension and their molecular phenotype was characterised by qRT-PCR, chromatin immunoprecipitation, immunocytochemistry and global transcriptome analysis. These findings were compared to the changes occurring in experimental chronic pancreatitis induced by pancreatic duct ligation and chronic caerulein administration. Results Acinar cells in suspension culture acquired a dedifferentiated phenotype characteristic of pancreatic embryonic progenitors, consisting of the co-expression of Ptf1a and Pdx1, presence of an embryonic-type PTF1 transcriptional complex, activation of the Notch pathway, and expression of additional pancreatic progenitor cell markers such as CpA1, Sox9 and Hnf1b. A senescence programme, associated with activation of Ras and ERK signalling, limited the proliferative capacity of the cells. A similar progenitor-like phenotype with activation of a senescence programme was observed in experimental chronic pancreatitis induced by pancreatic duct ligation or repeated caerulein administration, with the concomitant and differential activation of proliferation and senescence in distinct cell populations. Conclusions Acinar cells dedifferentiate into an embryonic progenitor-like phenotype upon suspension culture. This is associated with the activation of a senescence programme. Both processes take place in experimental chronic pancreatitis where senescence may contribute to limit tumour progression.
- Published
- 2010
- Full Text
- View/download PDF
44. Vessel probe CT protocol in the study of esophageal carcinoma: Can it improve preoperative T staging?
- Author
-
Arnaldo Scardapane, A. A. Stabile Ianora, Andrea Marzullo, M. Moschetta, Giuseppe Angelelli, Department of Radiology, Università degli studi di Bari Aldo Moro (UNIBA), and Department of Pathological Anatomy
- Subjects
Adult ,Male ,medicine.medical_specialty ,Staging ,Esophageal Neoplasms ,Esophageal cancer ,Sensitivity and Specificity ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Predictive Value of Tests ,Ct examination ,Histological diagnosis ,Image Processing, Computer-Assisted ,Carcinoma ,Humans ,Medicine ,Computed tomography ,Aged ,Neoplasm Staging ,CT protocol ,business.industry ,Esophageal wall ,MDCT ,General Medicine ,Middle Aged ,medicine.disease ,Oncology ,Research Design ,Sample Size ,030220 oncology & carcinogenesis ,Predictive value of tests ,cardiovascular system ,Female ,Surgery ,Radiology ,Tomography ,Tomography, X-Ray Computed ,business - Abstract
Aims This study aims to compare transverse images and vessel probe (VP) in MPR mode reconstructions obtained by 16-row MDCT with the histological findings in the preoperative T staging of esophageal cancer. Materials and methods Thirty-one patients (23 M, 8 F, mean age 63.2) with endoscopic and histological diagnosis of esophageal carcinoma underwent CT examination. Esophageal lumen was distended by CO 2 and a biphasic technique with 35s and 70s delay was used after intravenous injection of contrast material. Transverse and VP in MPR mode images were evaluated and the following parameters were considered: presence and location of the tumor; esophageal wall thickness and enhancement; depth of visceral wall invasion; periesophageal fat morphology and infiltration of adjacent organs. Preoperative staging was performed and then it was compared with the histological findings considered as reference standard. Results Sensibility, negative predictive and accuracy values were 67%, 64% and 79% by using axial images for preoperative T staging, while the use of VP increased the previous values up to 83%, 78% and 89%, respectively. Conclusions In the preoperative staging of esophageal cancer, VP in MPR mode reconstructions obtained by 16-row MDCT increase the sensibility and diagnostic accuracy values in the T parameter evaluation compared with axial images.
- Published
- 2010
- Full Text
- View/download PDF
45. β-Cell Replication Is Increased in Donor Organs From Young Patients After Prolonged Life Support
- Author
-
Ilse Weets, Peter In't Veld, Neelke De Munck, Miriam Pipeleers-Marichal, Kristien Van Belle, Zhidong Ling, Nicole Buelens, Frans Gorus, Patrick Haentjens, Daniel Pipeleers, Department of Embryology and Genetics, Pathological Anatomy, Pathologic Biochemistry and Physiology, Internal Medicine Specializations, Clinical Biology, and Surgery Specializations
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Child, preschool ,Insulin/metabolism ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Physiology ,Glucagon ,Statistics, Nonparametric ,Insulin-Secreting Cells/metabolism ,Insulin-Secreting Cells ,Diabetes mellitus ,Internal medicine ,Internal Medicine ,Insulin ,Humans ,Medicine ,Ki-67 Antigen/metabolism ,Child ,Pancreas ,Aged ,Pancreas/metabolism ,business.industry ,Cell growth ,CD68 ,Middle Aged ,Cell cycle ,medicine.disease ,Immunohistochemistry ,Tissue Donors ,Life Support Care ,Ki-67 Antigen ,cell proliferation ,Endocrinology ,medicine.anatomical_structure ,Islet Studies ,Regression Analysis ,Female ,Beta cell ,business - Abstract
OBJECTIVE This study assesses β-cell replication in human donor organs and examines possible influences of the preterminal clinical conditions. RESEARCH DESIGN AND METHODS β-Cell replication was quantified in a consecutive series of n = 363 human organ donors using double immunohistochemistry for Ki67 and insulin. Uni- and multivariate analysis was used to correlate replication levels to clinical donor characteristics and histopathologic findings. RESULTS β-Cell replication was virtually absent in most donors, with ≤0.1% Ki67-positive β-cells in 72% of donors. A subpopulation of donors, however, showed markedly elevated levels of replication of up to 7.0% Ki67-positive β-cells. β-Cell replication was accompanied by the increased replication of glucagon-, somatostatin-, and CA19.9-positive cells. Prolonged life support, kidney dysfunction, relatively young donor age, inflammatory infiltration, and prolonged brain death before organ retrieval were all found to be significantly associated with an increased level (≥90th percentile) of β-cell replication, with the first three risk factors being independent predictors. Increased β-cell replication was most often noted in relatively young donors (≤25 years) who received prolonged (≥3 days) life support (68%); in contrast, it was rare in donors with a short duration of life support regardless of age (1%). Prolonged life support was accompanied by increased levels of CD68+ and LCA/CD45+ infiltration in the pancreatic parenchyma. CONCLUSION These results indicate that preterminal clinical conditions in (young) organ donors can lead to increased inflammatory infiltration of the pancreas and to increased β-cell replication.
- Published
- 2010
- Full Text
- View/download PDF
46. Hemorrhagic regression of melanoma metastases during therapeutic vaccination: a report of three cases
- Author
-
Arlette De Coninck, Carlo Heirman, Annieta Goossens, An M. T. Van Nuffel, L. Pierret, Jurgen Corthals, Nicolas van Baren, G Verfaillie, Diane Roseeuw, Bart Neyns, Ellen Degreef, Kris Thielemans, Truus Roelandt, Aude Bonehill, Ivan Van Riet, Physiology, Skin function and permeability, Hematology, Pathological Anatomy, and Laboratory of Molecular and Medical Oncology
- Subjects
Adult ,Male ,Cancer Research ,Pathology ,medicine.medical_specialty ,Skin Neoplasms ,Central nervous system ,Hemorrhage ,Dermatology ,Cancer Vaccines ,Metastasis ,Central Nervous System Neoplasms ,Hematoma ,melanoma ,peptide vaccine ,Humans ,dendritic cell vaccine ,metastasis ,Medicine ,Spontaneous hemorrhage ,hemmorhagic ,Neovascularization, Pathologic ,business.industry ,Melanoma ,Vaccination ,Middle Aged ,medicine.disease ,Clinical trial ,medicine.anatomical_structure ,Oncology ,Disease Progression ,Female ,business ,Intracranial Hemorrhages ,Brain metastasis - Abstract
Melanoma metastases are characterized by pronounced neo-angiogenesis and spontaneous bleeding frequently occurring within central nervous system metastases. Clinically apparent spontaneous hemorrhage within subcutaneous melanoma metastases, however, is a rare event that coincides with progression of such metastases. We report, to our knowledge the first observation, on regression of subcutaneous metastases with hemorrhage of the overlying skin in three patients with stage IV melanoma who participated in clinical trials on therapeutic vaccination. In two patients, loss of arterial flow on Doppler ultrasound imaging was documented in the metastasis at the time of hematoma formation. One patient suffered from an intracranial hemorrhage in a subcentimetric brain metastasis coincident with the hemorrhagic regression of some of his skin metastases.
- Published
- 2009
- Full Text
- View/download PDF
47. Juvenile hormone binding protein traffic — Interaction with ATP synthase and lipid transfer proteins
- Author
-
Agata Kochman, Andrzej Ożyhar, Frédéric Lopez, Marian Kochman, Marta Zalewska, Karima Chaoui, Jean-Pierre Estève, Christiane Susini, Department of Biochemistry, Department of Pathological Anatomy, Medical University of Wroclaw, Institut de médecine moléculaire de Rangueil (I2MR), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-IFR150-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de pharmacologie et de biologie structurale (IPBS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Simon, Marie Francoise, Wrocław Medical University, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées- Institut Fédératif de Recherche Bio-médicale Institution (IFR150)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)
- Subjects
animal structures ,ATPase ,Fat Body ,Biophysics ,Mitochondrion ,Biology ,Moths ,Biochemistry ,Juvenile hormone binding protein ,03 medical and health sciences ,Hemolymph ,Animals ,[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,Arylphorin ,Lipophorin ,030304 developmental biology ,0303 health sciences ,ATP synthase ,030302 biochemistry & molecular biology ,fungi ,Membrane Proteins ,Cell Biology ,Mitochondrial Proton-Translocating ATPases ,Surface Plasmon Resonance ,Juvenile Hormones ,Cytosol ,Protein Transport ,Apolipoproteins ,Membrane protein ,Juvenile hormone ,biology.protein ,Insect Proteins ,[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,Hexamerin ,Carrier Proteins ,Plant lipid transfer proteins - Abstract
International audience; Juvenile hormone (JH) controls insect development, metamorphosis and reproduction. In insect hemolymph a significant proportion of JH is bound to juvenile hormone binding protein (JHBP), which serves as a carrier supplying the hormone to the target tissues. To shed some light on JHBP passage within insect tissues, the interaction of this carrier with other proteins from Galleria mellonella (Lepidoptera) was investigated. Our studies revealed the presence of JHBP within the tracheal epithelium and fat body cells in both the membrane and cytoplasmic sections. We found that the interaction between JHBP and membrane proteins occurs with saturation kinetics and is specific and reversible. ATP synthase was indicated as a JHBP membrane binding protein based upon SPR-BIA and MS analysis. It was found that in G. mellonella fat body, this enzyme is present in mitochondrial fraction, plasma membranes and cytosol as well. In the model system containing bovine F(1) ATP synthase and JHBP, the interaction between these two components occurs with K(d)=0.86 nM. In hemolymph we detected JHBP binding to apolipophorin, arylphorin and hexamerin. These results provide the first demonstration of the physical interaction of JHBP with membrane and hemolymph proteins which can be involved in JHBP molecule traffic.
- Published
- 2009
- Full Text
- View/download PDF
48. Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
- Author
-
Lionel D'Hondt, Alex Michotte, Eric Joosens, Bart Neyns, P. In't Veld, F. Bouttens, Jean-François Baurain, Jan Sadones, L. Verbeke, Theo Strauven, J. De Greve, Cristo Chaskis, Clinical sciences, Medical Oncology, Laboratory for Medical and Molecular Oncology, Laboratory of Molecullar and Cellular Therapy, Pathology, Pathological Anatomy, Anatomy, Immunology and Microbiology, UCL - MD/MINT - Département de médecine interne, UCL - (SLuc) Unité d'oncologie médicale, and UCL - (MGD) Service d'oncologie médicale
- Subjects
Male ,Adult ,Oncology ,medicine.medical_specialty ,EGFR ,Phases of clinical research ,Antineoplastic Agents ,Kaplan-Meier Estimate ,Antibodies, Monoclonal, Humanized ,Disease-Free Survival ,Internal medicine ,Glioma ,cetuximab ,medicine ,Clinical endpoint ,Humans ,Epidermal growth factor receptor ,Aged ,biology ,Cetuximab ,Brain Neoplasms ,business.industry ,glioblastoma ,Antibodies, Monoclonal ,Cancer ,Hematology ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,Chemotherapy regimen ,Confidence interval ,Surgery ,ErbB Receptors ,biology.protein ,Female ,Receptor, Epidermal Growth Factor ,business ,medicine.drug - Abstract
To evaluate the antitumor activity and toxicity of single-agent cetuximab in patients with recurrent high-grade glioma (HGG) after failure of surgery, radiation therapy, and chemotherapy.In this two-arm, open-label, phase II study patients were stratified according to their epidermal growth factor receptor (EGFR) gene amplification status. Cetuximab was administered intravenously at a dose of 400 mg/m(2) on week 1 followed by weekly dose of 250 mg/m(2). The primary end point for this study was the response rate in both study arms separately.Fifty-five eligible patients (28 with and 27 without EGFR amplification) tolerated cetuximab well. Three patients (5.5%) had a partial response and 16 patients (29.6%) had stable disease. The median time to progression was 1.9 months [95% confidence interval (CI) 1.6-2.2 months]. Whereas the progression-free survival (PFS) was6 months in the majority (n = 50/55) of patients, five patients (9.2%) had a PFS on cetuximab of9 months. Median overall survival was 5.0 months (95% CI 4.2-5.9 months). No significant correlation was found between response, survival and EGFR amplification.Cetuximab was well tolerated but had limited activity in this patient population with progressive HGG. A minority of patients may derive a more durable benefit but were not prospectively identified by EGFR gene copy number.
- Published
- 2009
- Full Text
- View/download PDF
49. Ileocolic invagination as a complication of a cecal adenocarcinoma
- Author
-
Johan De Mey, Frederik Vandenbroucke, Yves Van Nieuwenhove, Anne Hoorens, Inneke Willekens, Medical Imaging, Supporting clinical sciences, Faculty of Medicine and Pharmacy, Medical Imaging and Physical Sciences, and Pathological Anatomy
- Subjects
lcsh:Medical physics. Medical radiology. Nuclear medicine ,medicine.medical_specialty ,adenocarcinoma ,Enhanced ct ,business.industry ,invagination ,adult ,lcsh:R895-920 ,Invagination ,Gastrointestinal Radiology ,medicine.disease ,cecal adenocarninoma ,Surgery ,medicine.anatomical_structure ,Medicine and Health Sciences ,medicine ,Abdomen ,Adenocarcinoma ,Radiology, Nuclear Medicine and imaging ,Ileocolic invagination ,Cecal Adenocarcinoma ,Complication ,business ,CT - Abstract
Ileocolic invagination in the adult may be caused by adenocarcinoma and lead to intestinal obstruction. We report a case of a cecal adenocarcinoma that was complicated by an ileocolic invagination in a 38 year old female, diagnosed on a contrast enhanced CT scan of the abdomen and highlights the importance of contrast enhanced CT for diagnosis of ileocolic invagination.
- Published
- 2008
50. Tolerance of adjuvant letrozole outside of clinical trials
- Author
-
Jan B. Vermorken, Manon T. Huizing, Jan Lamote, D. Schallier, J. De Mey, A Meulemans, Bart Neyns, Claire Bourgain, Leonard Kaufman, Christine Collen, Robert Sacre, Christel Fontaine, G Verfaillie, J. P. De Greve, Medical Oncology, Laboratory of Molecular and Medical Oncology, Department of Embryology and Genetics, Radiation Therapy, Biomedical Statistics and Informatics, Medical Imaging and Physical Sciences, Pathological Anatomy, Surgery, Surgery Specializations, and Internal Medicine Specializations
- Subjects
Oncology ,medicine.medical_specialty ,Nausea ,medicine.medical_treatment ,Antineoplastic Agents ,Breast Neoplasms ,law.invention ,Cohort Studies ,Randomized controlled trial ,law ,Internal medicine ,Nitriles ,medicine ,Adjuvant therapy ,Humans ,Aromatase ,skin and connective tissue diseases ,Mastectomy ,Aged ,Retrospective Studies ,biology ,Aromatase Inhibitors ,business.industry ,Letrozole ,General Medicine ,Middle Aged ,Triazoles ,Arthralgia ,Surgery ,Postmenopause ,Clinical trial ,Chemotherapy, Adjuvant ,biology.protein ,Drug Therapy, Combination ,Female ,adjuvant letrozole ,medicine.symptom ,business ,Adjuvant ,Tamoxifen ,medicine.drug - Abstract
Recently aromatase inhibitors have become a standard care as an adjuvant treatment for many postmenopausal patients with hormone receptor positive early breast cancer. Adjuvant letrozole was made available either immediately postoperative, after 2-3 years of tamoxifen, or as an extended treatment after 5 years of tamoxifen. Between October 2003 and October 2005, we analyzed the subjective tolerence in 185 postoperative early breast cancer patients receiving letrozole outside of a clinical trial. The most prominent toxicity was musculoskeletal pain. In addition hot flushes, increased fatigue, nausea, vomiting, anorexia, mood disturbances, vaginal dryness, hair loss and rash were also recorded. In contrast to the prospective randomized clinical trials, a high drop-out rate of 20% was documented, mainly due to aromatase inhibitor-associated arthralgia syndrome interfering significantly with the daily life of our patients. Although adjuvant aromatase inhibitors have proven to be generally superior to tamoxifen in the adjuvant setting, it is important to focus attention on the tolerance during the adjuvant therapy and to balance this against the potential benefit in individual patients. Alternative options including switching to tamoxifen remain available.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.